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STELLINGEN 
1. De verstoring van intercellulaire communicatie via zogenaamde 'gap 
junctions' is een sleutelproces in de atherogenese. 
- Dit proefschrift. 
2. In de atherogenese zijn vooral geoxideerde lipoproteinen van belang en niet 
het cholesterol als zodanig. 
- R.A. Riemersma, D.A. Wood, CCA. Maclntyre, R.A. Elton, K.F. Gey, 
M.F. Oliver, Lancet 337, 1-5, 1991. 
- D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, J.L. Witztum, 
New Engl. J. Med. 320, 915-924, 1989. 
- Dit proefschrift. 
3. De 'response-to-injury' theorie en de 'monoclonale' theorie sluiten elkaar 
niet wederzijds uit. 
- Dit proefschrift. 
4. Aan het ontstaan van athérosclérose en kanker onder invloed van chemische 
factoren kunnen vergelijkbare mechanismen ten grondslag liggen. 
- M.W. Majesty, M.A. Reidy, E.P. Benditt, M.R. Juchau, Proc. Natl. 
Acad. Sei. 82, 3450-3454, 1985. 
- Dit proefschrift. 
5. De hypothese dat cholesterol-verlagende behandelingen kunnen leiden tot 
toename van het aantal zelfmoorden en andere ongevallen bevat 
onvoldoende argumenten op grond waarvan een oorzakelijk verband 
plausibel wordt gemaakt en is derhalve speculatief. 
- M.F. Muldoon, S.B. Manuck, K.A. Matthews, Br. Med. J. 301, 309-314, 
1990. 
- H. Engelberg, Lancet 339, 727-729, 1992. 
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6. Ondanks het feit dat het fenomeen apoptose al 20 jaar bekend is wordt 
hiermee in de toxicologie te weinig rekening gehouden. 
7. In het kader van de interdisciplinaire samenwerking dreigt de toxicologie 
zijn relatie met de biomoleculaire wetenschappen te verliezen. 
8. De veiligheidsfactor, welke toegepast wordt bij het vaststellen van de 
'acceptable daily intake', zou afhankelijk moeten worden van de 
beschikbare gegevens betreffende inter- en intraspecies variatie in 
toxicokinetiek en toxicodynamiek van deze stoffen. 
- A.G. Renwick, Food Additives and Contaminants 8, 135-150, 1991. 
9. Bij de beoordeling van onderzoeksgegevens wordt het belang van de 
reproduceerbaarheid in vergelijking met de statistische significantie in het 
algemeen ondergewaardeerd. 
10. Het verkrijgen van gelijke rechten voor kamerhuurder en -verhuurder 
draagt bij tot een oplossing van de kamemood. 
11. De wet van Archimedes kan als volgt gemodificeerd worden: een juiste 
combinatie van opwaartse arbeidsdruk en neerwaartse diepzee waterdruk is 
de drijfveer van het individu. 
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CHAPTER 1 
INTRODUCTION 
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GENERAL INTRODUCTION 
Atherosclerosis and its complications, such as myocardial infarction, stroke and peripheral 
vascular disease, are the major causes of morbidity and mortality in the Western World. 
The disease is characterized by an abnormal proliferation of smooth muscle cells in the 
intima of the artery vessel wall. Epidemiological studies show a strong association be-
tween atherosclerosis and a variety of environmental factors as cigarette smoke and agents 
causing hypertension (Hopkins and Williams, 1981; Seidel and Cremer, 1986). However, 
direct evidence linking these factors to atherosclerosis in a causal manner is lacking. 
Therefore, research of (atherogen-induced) molecular mechanisms critical to atherogenesis 
is needed. 
The assumption that certain chemicals could play a role in plaque formation comparable 
to the role carcinogens play in tumor formation is of toxicological interest. A parallel 
between carcinogenesis and atherogenesis is demonstrated by the facts that carcinogenic 
compounds, oncogenic viruses and radiation are able to induce lesions in a number of 
animal species, which shows similarities with atherosclerotic lesions found in humans 
(Albert et al., 1977; Bond et al., 1981; Gold, 1961; Fabricant et al., 1978; Majesky et 
al., 1985). 
If it is true that certain compounds with mutagenic potencies could also play an important 
role in human atherosclerosis, it would be of paramount importance to study the role of 
chemicals in the etiology of atherosclerosis in more detail. 
ETIOLOGY OF ATHEROSCLEROSIS 
A parallel between carcinogenesis and atherogenesis was brought forward by Benditt and 
Benditt (1973) and presented as the monoclonal hypothesis. Based on comparative 
immunochemical examination of glucose-6-phosphate dehydrogenase isoenzymes isolated 
from healthy arterial walls and atherosclerotic lesions, evidence was obtained for a 
monoclonal origin of atherosclerotic lesions. It was supposed that every lesion is in fact a 
benign tumor that has developed from one single smooth muscle cell, which has mutated 
through the action of chemical substances, ionizing radiation or viruses. Arguments in 
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favor of this hypothesis are that tumor initiators like chemical mutagens and promutagens 
(Albert et al., 1977; Bond et al., 1981), certain forms of radiation (Gold, 1961) and 
oncogenic viruses (Fabricant et al., 1978) can induce atherosclerotic lesions in laboratory 
animals. Furthermore, the polycyclic aromatic hydrocarbon carcinogen 7,12-
dimethylbenzo[a]anthracene, administered as an "initiator" followed by treatments with 
the "promoter" methoxane yielded aortic plaques in cockerels (Majesky et al., 1985). 
Another polycyclic aromatic hydrocarbon benzo[a]pyrene (BaP), present in e.g. cigarette 
smoke, can be converted by aortic tissue to diol epoxides (Juchau et al., 1976; Serabjit-
Singh et al., 1985; Bond et al., 1979; Majesky et al., 1983). Moreover, the "in vitro" 
DNA-damaging action of BaP metabolites was demonstrated using three test systems with 
different genetic endpoints used: sister-chromatid exchange, gene mutation at the 
hypoxanthine guanine phosphoribosyl transferase locus and unscheduled DNA synthesis 
(Zwijsen et al., 1990). These three test systems were also used to compare the metabolic 
activation capacity towards BaP of aorta smooth muscle cells of different species (rat, 
rabbit) and locations (thoracic and abdominal) in order to investigate a relation between 
the formation of mutagenic metabolites and the susceptibility to atherosclerosis. However, 
such a correlation was not observed (Zwijsen et al, 1990). As smooth muscle cells 
appeared to have a low metabolic capacity towards BaP the conclusion could be drawn 
that differences in susceptibility between species can not be explained solely on the basis 
of differences in biotransformation capacity, other factors are probably more important. 
Furthermore, studies by Penn et al. (1986) and Ahmed et al. (1990) provided additional 
evidence for the predictions of the monoclonal hypothesis by demonstrating that human 
coronary artery plaque DNA contained transforming potential and that mouse fibroblasts 
transfected with human plaque DNA give rise to tumors after subcutaneous injection into 
nude mouse. However, Yew et al. (1989) using the same material and methods, were not 
able to demonstrate transforming genes in atherosclerotic plaques. 
Despite the available support the monoclonal theory has not been widely accepted, which 
is partly due to the contradictory results. The generally accepted view of plaque 
development still is to regard smooth muscle cell proliferation as a reactive process, 
which occurs in response to stimuli such as injury or inflammation. According to that 
hypothesis smooth muscle cells involved in lesion formation do not genetically differ from 
the bulk of normal arterial smooth muscle cells. 
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The response-to-injury hypothesis of Ross (1976/1981) is based on the observations that 
endothelium denudation of arteries by a balloon embolectomy catheter produces a 
prominent platelet carpet on the denuded surface, followed by intimai proliferation, and 
that antiplatelet serum inhibits the smooth muscle proliferative response (Friedman et al., 
1977). It was proposed that smooth muscle cells in the wall normally exist in a quiescent 
state, but when the endothelium is injured, adhesion and aggregation of platelets to the 
damaged endothelium resulted in a release of factor(s), as platelet-derived growth factor 
(PDGF), that stimulate medial smooth muscle cells to migrate into the intima and to 
proliferate there. 
Another theory, the lipid hypothesis, states that circulating cholesterol is central to the 
pathogenic process, causing smooth muscle cell proliferation. Cholesterol bound to low 
density lipoproteins (LDL) is capable of damaging endothelium and of infiltrating into the 
tunica intima (Hollander et al., 1979). There, the cholesterol concentration of the cell is 
regulated by receptors which bind LDL-cholesterol complexes and then make the latter 
available to the cell for hydrolysis and esterification. The free cholesterol is partly used 
for membrane synthesis but also by means of a feedback mechanism suppresses the 
endogenous synthesis of cholesterol and the LDL-receptors. The accumulation of lipids in 
the proliferating cells would be due to a defective regulation mechanism, to an inadequate 
catabolism or to formation of insoluble cholesterol esters (Brown, 1981). 
All theories explaining atherogenesis, including the Benditt theory, are based on the 
concept of a defect growth control mechanism for smooth muscle. As impaired growth 
control is a key process in atherogenesis as well as in carcinogenesis and keeping in mind 
several parallels between the two diseases absences of growth control mechanism in 
tumors and atherosclerotic lesions this unifying aspect of the two diseases will be 
discussed in more detail in the following paragraphs. 
ABSENCE OF GROWTH CONTROL IN TUMORS AND PLAQUES 
Twnorigenesis 
Tumor development and progression may be viewed as a gradual emancipation of a clone 
of somatic cells from the complex controls that regulate its growth (Klein and Klein, 
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1985). All neoplastic cells have lost some measure of growth control and the cellular 
elements involved include growth factors, growth factor receptors and oncogenes 
(Bradshaw, 1986). Genes with either a normal or pathological function may influence the 
steps of tumor development in a positive or negative way. Such genes may be 
provisionally classified as oncogenes (genes that cause cancer), emerogenes (also called 
antioncogenes or tumor suppressor genes), and modulator genes (which can influence 
important but secondary malignant properties such as invasiveness, metatastic propensity, 
or the ability to generate an immune response). The discovery of oncogenes stems from 
the search for tumor viruses, stimulated by earlier successfull developments in 
microbiology and the epidemiology of infectious diseases. Afterwards, it was discovered 
that most of these genes are important cellular genes involved in the control of cell 
division. Undue activation of the cellular oncogenes by point mutation, retroviral 
insertion, chromosomal translocation or gene amplification can contribute to tumor 
development and progression in many systems (Bishop, 1987). Several of the currently 
known oncogenes can block specific steps in the maturation progress. Constituvely 
activated growth factors may inhibit maturation by urging their target cell to proliferate. 
Truncated growth factor receptors or faulty signal transducers may achieve a similar 
effect by emitting a continuous "go" signal in the absence of external stimulation. DNA-
binding proteins, like myc or myb, may block maturation by interfering with the 
condensation of chromatin which is the hallmark of terminal differentiation in many cells. 
Also the category of genes described as antioncogenes, tumor suppressor genes or 
emerogenes, respectively, can antagonize tumorigenic behavior at various levels. For 
example, the constitutive activation of a 'growth factor oncogene' may be canceled by the 
loss or dysfunction of the corresponding receptor, by a roadblock elsewhere within the 
complex pathway of signal transmission, as well as by changes in the responding target. 
In addition, oncogene-induced blocks to cell maturation may be overcome by strong 
inducers or circumvented by the use of alternative pathways (Klein, 1987). So, the 
regulation of cell growth is operated by a balanced action of growth factors, growth factor 
receptors and products of oncogenes, emerogenes and modulator genes. 
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Growth control mechanisms in arterial smooth muscle cells. 
In arterial vessels in general three coats surrounding the lumen are visible: the internal 
tunica intima, the intermediate tunica media and the external tunica adventitia. The 
tunicae have different functions and are each associated with different major cell types. 
The intima, responsible for exchange with the blood is characterized by the presence of 
endothelial cells, the media which is involved in the control of the diameter of medium 
and small vessels and the mechanical integrity of large ones, contains large numbers of 
smooth muscle cells and the adventitia, responsible for nourishing and protecting the 
vessels, contains connective tissue cells, nerve cells and smaller blood vessels (vasa 
privata). The smooth muscle cell is the main cell type involved in the pathogenesis of 
atherosclerosis, which proliferate and migrate from the arterial media into the subendothe-
lial space (Haust et al., 1960; Ross and Glomset, 1976; Moss and Benditt, 1970; 
Schwartz et al., 1986). However, interactions between smooth muscle cells and 
neighboring tissues, especially endothelial cells, platelets and monocyte/macrophages play 
an important role in the biology of the vessel wall and possibly participate in the 
pathogenesis of atherosclerosis. Three main mechanisms ,can explain smooth muscle 
growth control: 
a. Smooth muscle growth may be controlled by paracrine production of growth stimula-
ting or inhibiting factors released from blood cells and endothelial cells (Ross, 1990). 
b. Smooth muscle growth may be controlled by autocrine production of growth stimula-
ting or inhibiting factors (Wilcox et al., 1988). 
c. Smooth muscle growth may be controlled by cell-cell communication (this study). 
Paracrine production of growth factors for smooth muscle. 
A large number of molecules are mitogenic for quiescent smooth muscle cells in culture. 
Platelets release platelet-derived growth factor (PDGF), insuline-like growth factor-1 
(IGF-1), epidermal growth factor (EGF) and transforming growth factor ß (TGF-ß), 
growth factors which are able to assist smooth muscle replication (Clemmons et al., 1983; 
Oka and Orth, 1983; Associan et al. 1984; Tucker et al, 1984). 
Besides platelets, endothelial cells and activated macrophages also have the capacity to 
express the genes for growth factors, e.g. PDGF A and B as well as for interleukin 1 (II-
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1) (Martinet et al., 1986; Starksen et al., 1987; Bevilacqua et al., 1984). In addition, 
endothelial cells contain mitogenic heparin binding growth factors (HBGF), i.e. acidic and 
basic fibroblast growth factors (FGF) (Gospodarowicz et al., 1988). Lysates of 
endothelial cells containing FGF were able to stimulate smooth muscle cell replication in 
absence of growth factors (Gajdusek and Schwartz, 1984; Stavnow and Berg, 1987). 
Smooth muscle proliferation could, on the other hand, be theoretically ascribed to the loss 
of an inhibitory molecule present in the vascular wall (Castellot et al., 1981; Reilly et al., 
1987). Such molecules have been described, including heparans and proteoglycans, which 
are most prominent in quiescent cultures (Fritze et al., 1985). Both vascular endothelial 
and smooth muscle cells synthesize heparan sulphate molecules that can inhibit smooth 
muscle cell growth. These growth inhibitors can be inactivated by release of specific 
enzymes. Castellot et al. (1982) proposed that following endothelial denudation or injury, 
platelets are deposited on the subendothelium releasing heparitinase, platelet factor 4 and 
PDGF. The heparitinase cleaves heparin-like substances on the endothelium and smooth 
muscle into fragments which diffuse away, with additional inactivation of the substance 
by platelet factor 4 (Handin and Cohen, 1976). Thus it could be possible that endothelium 
injury allows smooth muscle growth by breakdown of heparan sulphate. 
Autocrine production of growth factors. 
Intimai smooth muscle cell proliferation can occur without the presence of platelets in the 
vascular lumen (Guyton and Karnovsky, 1979). So, the extent of cell replication is not 
dependent on the presence of platelet released factors and it is at least possible for smooth 
muscle cells to initiate DNA synthesis without interacting with platelets or other vessel 
wall cells (Fingerle and Kraft, 1987). In addition, arterial smooth muscle cells produce 
growth promoting substances, as PDGF-A, IGF-1, TGF ß and FGF, themselves (Clem-
mons and Van Wyk, 1985; Majesky et al., 1988; Gospodarowicz et al., 1988; Winkles et 
al., 1987). The hypothesis that an autocrine growth control mechanism is involved in 
atherogenesis is supported by the findings that plaque DNA contains an active transfor-
ming gene(s) (Penn et al., 1986; Ahmed et al., 1990). Further support can be derived 
from data demonstrating that PDGF-A expression is increased in human intimai lesion 
cells inside human atherosclerotic lesions and in cultured plaque cells (Wilcox et al., 
1988; Libby et al., 1988). Since human arterial smooth muscle cells can both produce and 
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respond to PDGF-A the increase of PDGF-A transcripts in intimai cells suggests an 
important role of this gene in atherogenesis. 
Intercellular communication. 
Gap junctions, which are composed of arrays of intramembraneous channels, act as 
specialized contact zones between neighboring cells and allow for the passage of ions and 
molecules of up to 1000 daltons (Simpson et al., 1977). Intercellular communication by 
gap junctions is considered to play an important role in maintaining and controlling cell 
growth, cell differentiation and homeostasis. It exerts an inhibitive effect on tumor cell 
precursors that contain activated oncogenes. Reduction of cell-cell communication by 
modulating the gap junctions could result in a clonal growth, ignoring neigboring normal 
cells. Indeed, evidence that tumor promoters can inhibit intercellular communication was 
first obtained in 1979 by Yotti et al. and Fitzgerald & Murray. Afterwards, a great deal 
of evidence shows that the blockage of gapjunctional communication might be an essential 
process in the promotion stage of carcinogenesis (reviewed by Yamasaki, 1990). Many 
types of promoting agents inhibit intercellular communication, which correlated well with 
their in vivo tumor promoting capacity (Trosko et al., 1982). Even several oncogene 
products such as from the src and ras genes, growth factors and viruses have shown to be 
associated with a decrease in cell-cell communication (Azarnia and Loewenstein, 1984; 
Chang et al., 1985; Madhukar et al., 1989). In addition, Land (1986) have shown that 
both myc- and ras- transformed rat fibroblasts can be suppressed by surrounding normal 
cells. So, blockage of junctional communication is now believed to be involved in the 
promotional phase of carcinogenesis. Since this control system is absent from tumors as 
well as plaques disturbance of cell-cell communication also could be involved in 
atherogenesis. 
AIM OF THE STUDY 
The main objective of this study is to investigate the modulation of growth control 
mechanisms critical to atherogenesis. As most experimental work has been performed in 
the framework of paracrine growth regulation we decided to focus our study on autocrine 
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growth regulation and gap junctional intercellular communication as a novel mechanism 
relevant to atherogenesis. The long term objective of the programme is to support the 
development of toxicological research models enabling the study of effects of chemicals 
on these growth control processes. In this study we tested the influence of some known 
atherogens on these growth control mechanisms. Therefore, we intended to use material 
of human origin as much as possible to enhance their relevance with regard to the human 
species. 
The atherogen-induced disturbances of growth control mechanism by inhibition of gap 
junctional intercellular communication are described in chapters 2,3 and 4. Chapters 5 
and 6 describe a transforming potential of atherosclerotic lesion DNA and low density 
lipoproteins, respectively. Chapters 5 and 7 deal with the possible involvement of PDGF-
A in atherogenesis. The summary and the conclusions are presented in chapters 8 and 9. 
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CHAPTER 2 
INHIBITION OF INTERCELLULAR COMMUNICATION IN SMOOTH 
MUSCLE CELLS OF HUMAN AND RATS BY LOW DENSITY LIPO-
PROTEINS, CIGARETTE SMOKE CONDENSATE AND TPA 
Inhibition by tumor promoting chemicals of intercellular communication via gap junctions 
may be important in carcinogenesis. In order to investigate the possible role of gap 
junctional intercellular communication in atherogenesis, we examined the effect of known 
inhibitors of intercellular communication, 12-0-tetradecanoylphorbol-13-acetate (TPA) 
and Cigarette Smoke Condensate (CSC), and Low Density Lipoproteins (LDL) and High 
Density Lipoproteins (HDL) on cellular communication in smooth muscle cells of human 
and rat by the microinjection-dye transfer technique. 
When Lucifer Yellow CH solution is injected into a cell, the average number of human 
and rat smooth muscle cells that become fluorescent is about 22 and 6, respectively. The 
tumor promoter (TPA) almost completely blocked gap junctional communication between 
smooth muscle cells at 100 ng/ml after 4 h exposure. LDL and CSC were able to inhibit 
intercellular communication in human and rat cells in a dose-dependent manner up to 
60%. LDL-pretreatment of human smooth muscle cells did not effect inhibition of 
intercellular communication, which suggests that this effect is mainly non-receptor media-
ted. HDL did not influence junctional communication. The results indicate that inhibition 
of intercellular communication may also contribute to the pathogenesis of atherosclerotic 
lesions, such as plaque. 
This chapter is based on: 
Renate M.L. Zwijsen, Laura H.J. de Haan, Jeanine S. Oosting, Hadewijch L.M. Pekelharing and Jan H. 
Koeman (1990) Inhibition of intercellular communication in smooth muscle cells of humans and rats by low 
density lipoprotein, cigarette smoke condensate and TPA. Atherosclerosis 85, 71-80. 
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INTRODUCTION 
Intercellular communication by gap junctions is considered an important cellular 
mechanism for regulating growth and differentiation (Loewenstein, 1979; Bennet and 
Spray, 1985). Gap junctions are hydrophilic channels employed for the exchange of 
important signal ions and molecules between cells. Inhibition of intercellular 
communication may be the key mechanism by which certain tumor promoting chemicals 
contribute to the etiology of chemical carcinogenesis (Loewenstein, 1979). Tumor 
promoting agents, such as 12-0-tetradecanoylphorbol-13-acetate (TPA) and cigarette 
smoke condensate (CSC), have been shown to inhibit intercellular communication in 
various cell types (Yotti et al., 1979a/b; Murray and Fitzgerald, 1979; Mosser and Bols, 
1982; Enomoto and Yamasaki, 1985; Newbold and Amos, 1981; Ruch et al., 1987; 
Rutten et al., 1988; Hartman and Rosen, 1983). 
The fibrous plaque is regarded as the most characteristic vascular lesion of atherosclero-
sis. Plaques represent abnormal proliferations of smooth muscle cells, which seem to have 
a monoclonal character for isoenzymes of glucose-6-phosphatedehydrogenase (G-6-PD) 
(Benditt and Benditt, 1973; Pearson et al., 1975). The finding of a high frequency of 
monoclonality for G-6-PD in atherosclerotic plaques led to the suggestion that the plaque 
is a primary benign neoplasm (Benditt and Benditt, 1973). Atherosclerotic lesions can be 
ultimately formed from single mutated smooth muscle cells in the intima of large arteries. 
After initiation of a preneoplastic lesion followed by a promotion stage, the smooth 
muscle cells proliferate and ultimately form a tumor: the plaque. 
Several investigations provide support for the monoclonal hypothesis of Benditt (Paigen et 
al., 1985; Albert et al., 1977; Penn et al., 1986). Carcinogens such as 3-methyl-
cholantrene, benzo(a)pyrene and dimethylbenzantracene induce atherosclerotic lesions in 
laboratory animals (Paigen et al., 1985; Albert et al., 1977). In addition, Penn and 
colleagues (Penn et al., 1986) provide evidence for the existence of an active human 
oncogene in plaques by transformation of cultured mouse fibroblast cells with transfected 
DNA from human plaques. This would imply that mutations lead to activation of 
oncogenes in the cells that make up the atherosclerotic plaque, a process demonstrated 
previously only in cancer cells. 
The aim of the present investigation was to study the effect of lipoproteins and cigarette 
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smoke condensate (CSC) on gap junctional communication in smooth muscle cells of 
human and rat. Intercellular communication was measured by a dye transfer assay using 
arterial smooth muscle cells of human and rat. The following aspects were studied: (a) the 
effect of known inhibitors of intercellular communication, the tumorpromotors TPA and 
CSC, on communication in human and rat smooth muscle cells; (b) the effect of LDL and 
HDL on intercellular communication in this model system. 
MATERIALS AND METHODS 
Reagents 
LDL, HDL, 12-0-tetradecanoylphorbol-13-acetate (TPA) and Lucifer Yellow CH were 
purchased from Sigma Chemical Co (U.S.A.). Cigarette-smoke condensate (CSC) was a 
gift from ITV-TNO, Zeist, The Netherlands. CSC and TPA were dissolved in dimethyl-
sulfoxide (DMSO). DMSO and Triton X-100 were obtained from E. Merck EG (F.R.G.). 
Sodium pyruvate was obtained from BDH Chemicals Ltd (U.K.) and NADH from 
Boehringer (F.R.G.). 
LDL purity 
The LDL purity was controlled on breakdown and oxidation products by means of 
agarose gelelectrophoresis and the thiobarbituric acid reactive substances (TBARS) assay 
as previously described (Steinbrecher et al., 1984). The amount of malondialdehyde 
(MDA) equivalent was determined using freshly diluted 1,1,3,3-tetramethoxypropane 
(Aldrich, F.R.G.) as a standard. The degree of LDL oxidation was expressed in 
nanomoles of MDA equivalent per milligram of LDL-cholesterol. No degradation or 
oxidation of control LDL preparations were observed. This was shown by the small band 
of lipid staining (fat red 7B) after agarose gelelectrophoresis and the TBARS values for 
control LDL preparations, which were always lower than 0.2 nmol MDA/mg LDL-
cholesterol. 
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Cell culture 
Arterial smooth muscle cells were obtained from arteries of human umbilical cord and 
abdominal aorta of Wistar rats (6-8 months) by an expiant technique Gloss, 1971). In 
brief, arteries were isolated aseptically, unwanted tissue was dissected off and the tissue 
was chopped in pieces of 1 mm. The pieces were washed 3-5 times with PBS (Oxoid 
Limited, UK), placed on glass coverslips in 6-well dishes (Costar, U.S.A) and incubated 
for 10 days in Eagle's Minimal Essential Medium (EMEM; Flow Laboratories, UK) 
supplemented with 5 % Fetal Calf Serum (FCS, Gibco, UK) and 5 % human serum 
(Sigma Chemicals, St. Louis, MO) or 10 % FCS (human and rat cells, respectively), 
gentamycin (50 Mg/ml; Gibco) and amphotericin B (1.5 Mg/ml; Gibco) in a 37 °C, 5 % 
C02 humidified air environment. 
After 10-15 days, if sufficient periferal growth had occurred, cells were subcultured in 
flasks (Costar) by trypsination. Distinction between smooth muscle, fibroblasts and 
endothelial cells was made by means of fluoresceinated antibodies against smooth muscle 
actin (Chamley et al., 1977) and the growth pattern of smooth muscle cells in culture 
(hills and valleys). The smooth muscle cell cultures which were used in our studies were 
free of fibroblasts and endothelial cells. 
Measurement of intercellular communication by means of fluorescent dye transfer 
Smooth muscle cells (passage 2-3) were plated at a concentration of 2 x 10s cells per well 
(3.5 cm diameter) on a glass cover slip (1.8 x 1.8 cm) and cultured for two days in 
EMEM supplemented with FCS (5 %) and human serum (5 %) or 10 % FCS and 
antibiotics for human or rat cells, respectively. The experiments with TPA and CSC were 
performed in this medium one day later. In the experiments with lipoproteins the cells 
were exposed to lipoproteins in Ham's F10 medium containing 10 % lipoprotein deficient 
human serum (LPDS; Sigma) after a pretreatment with Ham's F10 and 10 % LPDS for 
24 h, ensuring activation of the LDL receptor (Bierman and Albers, 1977). 
Modulation of the LDL receptor activity was performed by a pretreatment of human 
smooth muscle cells with Ham's F10 medium containing 10% lipoprotein deficient human 
serum with or without 50 ßg LDL-cholesterol/ml for 24 h. After pretreatment cells were 
incubated with LDL (0-200 ßg LDL-cholesterol/ml) during 24 h followed by measure-
ment of intercellular communication. 
30 
Intercellular communication was determined in subconfluent cell cultures after micro-
injection of a 20 % Lucifer Yellow CH (Sigma) (in 0.33 M Lithium Chloride) solution in 
a single cell close to the nucleus (Enomoto et al., 1984). In each smooth muscle cell 
culture at least 20 individual cells were microinjected using a vertical injection system 
(Olympus injectoscoop IMT-2-syf) (Yamamoto and Furusawa, 1978) with a dye filled 
capillary glass tip (Clark, Pangbourne, UK). The glass capillary tip was prepared by an 
automatic magnetic puller (Narishige, Tokyo, Japan) with a tip diameter of 1 ßtn. The 
filled cells were checked with phase-contrast and fluorescense microscopy directly after 
microinjection. 15-20 min. after the first injection the number of communicating cells was 
determined. Photographs were made using an Olympus OM 2S camera using the injecto-
scope and a Kodak technical pan 2415 film. 
Each experiment was performed in triplicate and at least two independent tests were done. 
The significance of the values was tested with a student t-test (Lindgren, 1976). 
Cytotoxicity assay 
2.10s cells were seeded into 24-well tissue culture plates (Costar). The next day the wells 
were rinsed with HBSS and the cells were (pre)incubated as described above. After the 
treatment 400 nl samples of the media were taken from each well and centrifuged. 
Lactate dehydrogenase (LDH) activity was measured in 100 ;ul supernatant. The 
maximum release of LDH was obtained by scraping the cells from the bottom after 
addition of 1 ml 0.5 % Triton X-100 in 0.1 M phosphate buffer (pH 7.5). After sonifica-
tion for 5 min and centrifugation the LDH activity was measured in the supernatant 
(Mitchell et al., 1980). Each experiment was performed in triplicate. 
RESULTS 
Lucifer Yellow CH injected into single human or rat cells spread over an average over 22 
and 6 surrounding cells, respectively (table 2.1). 24 h (Pre)treatment with medium contai-
ning 10 % lipoprotein deficient serum for 24 h resulted in the same intercellular commu-
nication as that produced by culture medium in both rat and human cells. The potent 
tumor promoting agent TPA (100 ng/ml) used as positive control caused an almost 
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Table 2.1 Number of fluorescent smooth muscle cells of human and rat after treatment 
with culture medium containing TPA, DMSO or (Ham's F10) medium with 
lipoprotein deficient serum (LPDS). 
compound 
LPDS 
DMSO 
TPA 
-
LPDS 
DMSO 
TPA 
time (h) 
24 
4 
4 
-
24 
4 
4 
concentration 
10.0 
0.1 
100.0 
-.-
10.0 
0.1 
100.0 
% 
% 
ng/ml 
% 
% 
ng/ml 
species 
human 
human 
human 
human 
rat 
rat 
rat 
rat 
no. of fluorescent cells 
21.9 
20.5 
19.2 
1.9 
5.9 
5.5 
6.4 
1.2 
± 0.3 
± 0.5 
± 2.0 
+ 0.1 
± 0.6 
± 0.7 
± 1.3 
+ 0.2 
Values are mean ± S.E.M. 
complete inhibition after 4 h in smooth muscle cells of both species (table 2.1). The 
solvent DMSO (0,1 %) did not have an effect on the cell-cell communication. 
The effects of lipoproteins and CSC on gap junctional communication were measured 
24 h after the start of the incubation. No cytotoxic effects were seen at concentrations 
and treatment times of the compounds used in the experiments. Values of LDH activity 
after exposure to lipoproteins and CSC varied between 94% and 103% of the control 
values. When LDL was added to lipoprotein-deficient serum to achieve cholesterol con-
centrations of 50, 100 and 200 Mg/ml of medium a dose-dependent decrease in 
communication in both human and rat smooth muscle cells was detected. The inhibition of 
cell-cell communication by LDL was the same for human and rat cells. The data are 
presented in Figs. 2.1 and 2.2. A significant inhibition of communication between arterial 
smooth muscle cells was present (30-35 %) at the lowest concentration of LDL tested in 
both species; the degree of inhibition was increased to about 45 % when the LDL-
cholesterol concentration was raised to 100 Mg/ml and increased to circa 55 % when the 
concentration of LDL-cholesterol was raised to 200 Mg/ml. Fig. 2.2b shows the time 
course of the effect of LDL on intercellular communication. For human cells, significant 
inhibition of gap junctional communication occurred after 15 h and increased to 66 % 
after 48 h treatment with 100 ßg LDL-cholesterol/ml (p< 0.005). For rat cells, after 4 h 
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Fig. 2.1 Photomicrographs depicting Lucifer yellow transfer in cultures of human smooth 
muscle cells. Cells injected with Lucifer yellow dye are indicated by the arrows. Bar = 
25 ßm. (A) Phase contrast micrograph of untreated smooth muscle cells. (B) Lucifer 
yellow fluorescence in the same field. (C) Phase contrast micrograph of smooth muscle 
cells after exposure to 100 ßg LDL-cholesterol/ml for 24 h. (D) Lucifer yellow fluores-
cence in the same field. 
incubation of 100 ßg LDL-cholesterol/ml, the intercellular communication was significant 
inhibited by 38 %. After 7.5 h the inhibition was maximal (45 %) and the inhibition 
persisted for another 40 h. So, the LDL-induced effects on human cells were enhanced 
after prelonged treatment in contrary to what happened in rat cells (p< 0.025 after 48 h). 
In contrast to LDL, HDL had no marked effect on the cell-cell communication. Smooth 
muscle cells of human and rat treated with HDL-cholesterol concentrations between 
50 and 200 Mg/ml for 24 h showed no significant differences in intercellular communica-
tion (Fig. 2.2b). Pretreatment of the human cells with 50 ßg LDL-cholesterol/ml and 
subsequent addition of LDL levels between 0 - 200 ßg cholesterol/ml resulted in an 
inhibition of intercellular communication, which was comparable with pretreatment with 
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intercellular communication (%) intercellular communication (%) 
100 200 
concentration cholesterol (ug/ml) 
Fig. 2.2 Intercellular communication in smooth muscle cells of human and rat after 
exposure to different LDL or HDL concentrations for 24 h. (a) and for different periods 
at 100 ßg cholesterol/ml (b). Values are mean ± S.E.M. Open symbols: human cells; 
closed symbols: rat cells; circles: LDL; triangles: HDL. * Significant different from 
controls, p < 0.005, + Significant different from controls, p < 0 . 0 1 . 
intercellular communication (%) 
100 200 
concentration cholesterol(u.g/ml) 
Fig. 2.3 Effect of LDL on intercellular communication in human smooth muscle cells 
with pretreatment (open circles) or without pretreatment (closed circles) with 50 ßg LDL-
cholesterol/ml for 24 h. Values are mean + S.E.M. * Significant different from controls, 
p<0.005, + Significant different from controls, p<0.01. 
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lipoprotein deficient medium (Fig. 2.3). 
Figure 2.4a shows that cigarette smoke condensate is also able to inhibit the communi-
cation between smooth muscle cells of human and rat. Exposure of smooth muscle cells 
to 27.5 fig CSC per ml for 24 h caused an inhibition of communication between human 
or rat cells of 11 % and 37 %, respectively. At 55 y.glm\ the values increased to 28 
% and 43 %, respectively; a further increase of the inhibition to about 50 % is observed 
when the concentration of CSC is raised to 110 pglm\. At this concentration no 
differences were observed in CSC induced effects between human and rat smooth muscle 
cells. Fig. 2.4b shows the time course of the effects of CSC (55 /ig/ml) on gap junctional 
communication in human and rat cells. After 4 h exposure to CSC the intercellular 
communication in human cells and rat cells is significantly inhibited by 32 % and 26 %, 
respectively. Exposure to CSC (55 Mg/ml) for prolonged times (44 h) caused a further 
increase of inhibition by 65 % and 58 % in human and rat cells, respectively. 
intercellular communication (%) 
100-
intercellular communication (%) 
5 
- , , -j 
50 100 
concentration CSC lug/ml) 
Fig. 2.4 Intercellular communication between smooth muscle cells of human and rat after 
exposure to different concentrations of Cigarette Smoke Condensate (CSC) for 24 h. (a) 
and for different periods at 55 Mg/ml (b)- Values are mean ± S.E.M. Open circles: 
human cells; closed circles: rat cells. * Significant different from controls, p < 0.005, + 
Significant different from controls, p<0.05. 
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DISCUSSION 
In this study intercellular communication was measured in smooth muscle cells of the 
human and the rat with the dye-transfer technique. In these cells cell-cell communication 
was almost completely blocked by the tumor promoter TPA, a known inhibitor of inter-
cellular communication in various other cell types (Mosser and Bols, 1982; Enomoto and 
Yamasaki, 1985; Newbold and Amos, 1981; Rutten et al., 1988). The present study also 
revealed that CSC markedly reduced gapjunctional communication between smooth 
muscle cells as in fibroblasts and epithelial cells (Rutten et al., 1988; Hartman and Rosen, 
1983). In addition LDL, in contrast to HDL, decreased intercellular communication in a 
dose-dependent way. Apparently not only the quantity of lipoproteins is of importance, 
but also the lipoprotein structure. The findings are consistent with epidemiological data 
linking high LDL (Smith and Slater, 1972) and low HDL (Glueck, 1976; Glueck et al., 
1977; Gordon et al., 1977; Miller and Miller, 1975) plasma cholesterol concentrations to 
atherosclerosis. 
We have investigated the hypothesis that the LDL-induced effects on intercellular 
communication are mainly receptor-mediated by modulating the LDL receptor activity. It 
was reported that activation of LDL receptors in smooth muscle cells occurs after 
preincubation with lipoprotein deficient medium (Bierman and Albers, 1977). 
Preincubation with LDL suppress the receptor binding activity (Bierman and Albers, 
1977) and in case of a receptor-mediated process a subsequent addition of higher LDL 
levels should diminish the effects induced after pretreatment with lipoprotein deficient 
medium. We observed that the effect on intercellular communication was independent of 
LDL-pretreatment. This indicates that the inhibition on intercellular communication by 
LDL is mainly a non-receptor mediated process, possible by uptake of LDL via bulk 
phase endocytosis (Goldstein and Brown, 1974). 
Intercellular communication is thought to be essential in the control of cellular homeo-
stasis, growth and division (Loewenstein, 1979) and involves the passage of low 
molecular weight molecules and ions between adjacent cells via gap junctions (Simpson et 
al., 1977). Various substances which may be intimately related to the control of cell 
proliferation pass through the gap junction (Flagg-Newton and Loewenstein, 1979; Merk 
et al., 1972; Sheridan, 1974). It is proposed that the interchange of regulatory molecules 
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(chalones) across gap junctions can limit clonal expansion of (initiated) cells (Yotti et al., 
1979a; Trosko et al., 1983). Blockage of the transfer of such regulatory factors between 
normal and initiated cells could lead to abnormal cell proliferation (Trosko et al., 1983; 
Yamasaki, 1987). The arterial smooth muscle initiated cells can be recruited to proliferate 
and form atherosclerotic lesions under conditions in which they are no longer affected by 
chalones. This may be one mechanism by which atherogens, enhance cell proliferation of 
intimai smooth muscle cells, ultimately leading to plaque formation. The intercellular 
junctions which are involved in carcinogenic mechanisms can also be involved in 
atherogenic mechanisms. 
The development of an atherosclerotic lesion is characterised by a proliferation of arterial 
smooth muscle cells and an accumulation of free and esterified cholesterol, which is 
chiefly derived from plasma lipoproteins (Smith, 1974; Zilversmit, 1968), mainly LDL-
cholesterol. Cholesterol is an important component of cellular membranes and 
incorporation of cholesterol and/or cholesterol (oxidation) derivatives in the membrane 
can cause dysfunction of the membrane (Sevanian and Peterson, 1986; Chang et al., 
1988). Since gap junctions are membrane structures, changes in the membrane 
microenvironment could alter the functional capacity of gap junctions. This might be an 
explanation for the mechanism by which LDL induced inhibition of junctional communi-
cation. LDL is the major carrier of cholesterol towards the tissues, in contrast to HDL, 
which is a carrier of cholesterol from peripheral tissues to the liver. It cannot be excluded 
that other components of the lipoproteins than cholesterol(derivatives) contribute to the 
alterations in gap junctional communication. Further studies are needed to elucidate the 
mechanisms responsible for the LDL- and CSC-induced alterations of the gap junction 
mediated communication between smooth muscle cells. 
Acknowledgements: 
The authors thank Drs. C.W.D.A. Klapwijk and his co-workers for their cooperation, Dr. 
G.M. Alink for critical review of the manuscript, J.M. Lam-Cauwenberg and M.E.M. 
Heitkönig for typing the manuscript. 
This work forms part of a research program which is supported by the Netherlands Heart 
Foundation. We are also indebted to the Directory for Nutrition and Quality Affairs of the 
Ministry of Agriculture, Nature Management and Fisheries for their support. 
37 
References 
Albert, R., Vanderlaan, M., Burns, F.J., and Nishizumi, M. (1977) Effect of carcinogens on chicken 
atherosclerosis. Cancer Res. 37, 2232-2235. 
Benditt, E.P., and Benditt, J.M. (1973) Evidence for the monoclonal origin of human atherosclerotic pla-
ques. Proc. Natl. Acad. Sei. USA 70, 1753-1756. 
Bennett, M.V.L., and Spray, D.C. Gap Junctions. Cold Spring Harbor Laboratory Press. Cold Spring 
Harbor, N.Y. (1985). 
Bierman, E.L., and Albers, J. (1977) Regulation of low density lipoprotein receptor activity by cultured 
human arterial smooth muscle cells. Biochim. Biophys. Acta 488, 152-160. 
Chamley, J.H., Gröschel-Stewart, U., Campbell, G.R., and Burnstock, G. (1977) Distinction between 
smooth muscle, fibroblasts and endothelial cells in culture by the use of fluoresceinated antibodies against 
smooth muscle actin. Cell. Tiss. Res. 177, 445-457. 
Chang, C.C., Jone, C , Trosko, J.E., Peterson, A.R., and Sevanian, A. (1988) Effect of cholesterol 
epoxides on the inhibition of intercellular communication and on mutation induction in Chinese hamster V79 
cells. Mut. Res. 206, 471-478. 
Enomoto, T., Martel, N., Kanno, Y., and Yamasaki, H. (1984) Inhibition of cell communication between 
Balb/c 3T3 cells by tumor promotors and protection by cAMP. J. Cell Physiol. 121, 323-333. 
Enomoto, T., and Yamasaki, H. (1985) Phorbol-ester mediated inhibition of intercellular communication in 
Balb/c 3T3 cells: relationship to enhancement of cell transformation. Cancer Res. 45, 2681-2688. 
Flagg-Newton, J., and Loewenstein, W.R. (1979) Experimental depression of junctional membrane 
permeability in mammalian cell culture. A study with trace molecules in the 300 to 800 dalton range. J. 
Membr. Biol. 50, 65-100. 
Glueck, C.J. (1976) Alpha-lipoprotein cholesterol, beta-lipoprotein cholesterol and longevity. Artery 2, 196-
197. 
Glueck, C.J., Gartside, P.S., Steiner, P.M., Miller, M., Todhunter, T., Haaf, J., Pucke, M., Terrana, M., 
Fallal, R.W., and Kashyap, M.L. (1977) Hyperalpha- and hypobeta-lipoproteinemia in octogenarian 
kindreds. Atherosclerosis 27, 387-406. 
Goldstein, J.L., and Brown, M.S. (1974) Binding and degradation of low density lipoproteins by cultured 
human fibroblasts. J. Biol. Chem. 249, 5153-5162. 
Gordon, T., Castelli, W.P., Hjortland, M.C., Kännel, W.B., and Dawber, T.R. (1977) High density 
lipoprotein as a protective factor against coronary heart disease. The Framingham Study, Amer. J. Med. 62, 
707-714. 
Hartman, T.G., and Rosen, J.D. (1983) Inhibition of metabolic cooperation by cigarette smoke condensate 
and its fractions in V79 Chinese hamster lung fibroblasts. Proc. Natl. Acad. Sei. USA 80, 5305-5309. 
Lindgren, B.W., Statistical Series, London, Collier and Macmillan, 1976. 
Loewenstein, W.R. (1979) Junctional intercellular communication and the control of growth. Biochim. 
Biophys. Acta 560, 1-65. 
38 
Merk, F.B., Boticelli, A., and Albright, J.T. (1972) An intercellular respons to estrogens by granulosa cells 
in the ovary. An electron microscope study. Endocrinology 90, 992-1007. 
Miller, G.J., and Miller, N.E. (197S) Plasma high density lipoprotein concentration and development of is-
chaemic heart disease. Lancet i, 16-19. 
Mitchell, D.B., Santone, K.S., and Acosta, D. (1980) Evaluation of cytotoxicity in cultured cells by 
enzyme leakage. J. Tissue Cult. Meth. 6, 113-116. 
Mosser, D.D., and Bols, N.C. (1982) The effect of phorbols on metabolic cooperation between human fi-
broblasts. Carcinogenesis 3, 1207-1212. 
Murray, A.W., and Fitzgerald, D.J. (1979) Tumor promoters inhibit metabolic cooperation in cocultures of 
epidermal and 3T3 cells. Biochem. Biophys. Res. Commun. 91, 395-401. 
Newbold, R.F., and Amos, J. (1981) Inhibition of metabolic cooperation between mammalian cells in cul-
ture by tumor promoters. Carcinogenesis 2, 243-249. 
Paigen, B., Havens, M.B., and Morrow, A. (1985) The effect of 3-methylcholantrene on the development 
of aortic lesions in mice. Cancer Res. 45, 3850-3855. 
Pearson, T.A., Wang, A., Solez, K. and Heptinstall, R.H. (1975) Clonal characteristics of fibrous plaques 
and fatty streaks from human aortas. Am. J. Pathol. 81, 379-387. 
Perm, A., Garte, S.J., Warren, L., Nesta, D., and Mindich, B. (1986) Transforming gene in human athero-
sclerotic plaque DNA. Proc. Natl. Acad. Sei. USA 83, 7951-7955. 
Ross, R. (1971) The smooth muscle cell II: Growth of smooth muscle cell in culture and formation of 
elastic fibers. J. Cell Biol. 50, 172-186. 
Ruch, R.J., Klaunig, J.E., and Pereira, M.A. (1987) Inhibition of intercellular communication between 
mouse hepatocytes by rumor promoters. Tox. Appl. Pharm. 87, 111-120. 
Rutten, A.A.J.J.L., Jongen, W.M.F., de Haan, L.H.J., Hendriksen, E.G.J., and Koeman, J.H. (1988) 
Effect of retinol and cigarette-smoke condensate on dye-coupled intercellular communication between 
hamster tracheal epithelial cells. Carcinogenesis 9, 315-320. 
Sevanian, A., and Peterson, A.R. (1986) The cytotoxic and mutagenic properties of cholesterol oxidation 
products. Fd. Chem. Toxic. 24, 1103-1110. 
Sheridan, J.D. Electric coupling of cells and cell communication. In Cox, R.P. (eds), Cell Communication, 
John Wiley and Sons, NY, pp 31-42, 1974. 
Simpson, L., Rose, B., and Loewenstein, W.R. (1977) Size limit of molecules permeating the junctional 
membrane channels. Science 195, 294-296. 
Smith, E.B., and Slater, R.S. (1972) Relationship between low density lipoprotein in aortic intima and 
serum lipid levels. Lancet 1, 463-469. 
Smith, E.B. (1974) The relationship between plasma and tissue lipids in human atherosclerosis. Adv. Lipid 
Res. 12, 1-49. 
Steinbrecher, U.P., Parthasarathy, S., Leake, D.S., Witztum, J.L., and Steinberg, D. (1984) Modification 
of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density 
lipoprotein phospholipids. Proc. Natl. Acad. Sei. USA 81, 3883-3887. 
39 
Trosko, J.E., Chang C.C., and Metcalf, A. (1983) Mechanisms of tumor promotion: potential role of 
intercellular communication. Cancer Invest. 1, 511-526. 
Yamamoto, F., and Furusawa, M. (1978) A simple microinjection technique not employing a 
micromanipulator. Exp. Cell Res. 117, 441-445. 
Yamasaki.H., Concepts and theories in carcinogenesis. In Maskens, A.P. et all (eds), Elsevier Science 
Publishers B.V., Amsterdam, pp 117-133, 1987. 
Yotti, L.P., Chang, C.C., and Trosko, J.E. (1979) Elimination of metabolic cooperation in cocultures of 
epidermal and 3T3 cells. Biochem. Biophys. Res. Commun. 91, 1089-1091. 
Yotti, L.P., Chang, C.C., and Trosko, J.E. (1979) Elimination of metabolic cooperation in Chinese hamster 
cells by a tumor promoter. Science 206, 1089-1091. 
Zilversmit, D.B. (1968) Cholesterol flux in the atherosclerotic plaque. Ann. NY Acad. Sei. 149, 710-724. 
40 
CHAPTER 3 
MODULATION OF LOW DENSITY LIPOPROTEIN-INDUCED 
INHIBITION OF INTERCELLULAR COMMUNICATION BY 
ANTIOXIDANTS AND HIGH DENSITY LIPOPROTEINS 
In order to study the capacity of antioxidants and high density lipoproteins (HDL) to 
modulate the effects of low density lipoproteins (LDL) on intercellular communication, 
arterial smooth muscle cells and a dye transfer method were used. LDL, in contrast to 
HDL, inhibited communication between human arterial smooth muscle cells of umbilical 
cords and human aorta in a dose-dependent way. LDL, which can be oxidized, as 
detected by lipid peroxidation assay and gel electrophoresis, did not influence cell-cell 
communication in the presence of antioxidants BHT, a-tocopherol and glutathione. These 
results suggest that LDL must undergo oxidative modification before it can influence cell-
cell communication. Like antioxidants, HDL diminished LDL-induced inhibition of 
communication. This study suggests that modulation of gap junctional communication by 
the balance of HDL and LDL in plasma may influence atherogenesis. 
This chapter is based on: 
Renate M.L. Zwijsen, Laura H.J. de Haan, Jan-Albert Kuivenhoven and Ineke C.J. Nusselder (1991) 
Modulation of low density lipoprotein-induced inhibition of intercellular communication by antioxidants and 
high density lipoproteins. Fd. Chem. Toxic. 29, 615-620. 
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INTRODUCTION 
Intercellular communication through gap junctions allows direct cell-to-cell transfer of 
compounds of low molecular weight, and may therefore play a role in the control of cell 
proliferation and differentiation and in tissue homeostasis (Gilula, 1977; Loewenstein, 
1979; Yamasaki et al., 1984). The disruption of gap junctional communication by various 
chemicals is thought to be a factor in teratogenesis and the promotion of carcinogenesis 
and atherogenesis (Gilula, 1977; Warner et al., 1984; Weinstein et al., 1976; Zwijsen et 
al., 1990). This hypothesis is strongly supported by the fact that all tumor promoters that 
have been investigated block intercellular communication in cultured cells (Murray and 
Fitzgerald, 1979; Enomoto et al., 1981). In addition, it has been shown that transformed 
cells loose their ability to communicate with surrounding normal cells (Yamasaki et al., 
1987). A number of oncogene products (e.g. those from src and ras), growth factors and 
viruses have also been shown to be associated with a decrease in gap junctional 
communication (Chang et al., 1985; Azarnia and Loewenstein, 1984; Madhukar et al., 
1989). 
It has been demonstrated that low density lipoproteins (LDL) also act as an inhibitor of 
intercellular communication (Zwijsen et al., 1990). Elevated plasma concentrations of 
these lipoproteins have been shown to be associated with accelerated atherogenesis 
(Tyroler, 1987; Goldstein and Brown, 1977; Steinberg, 1983). Recent studies have 
demonstrated that oxidative modification of LDL may play an important role in its athero-
genic effect (Steinberg, 1988; Triau et al., 1988; Quinn et al., 1985; Steinberg et al., 
1989). This oxidation occurs in vivo and in vitro and is totally inhibited by antioxidants, 
such as butylated hydroxytoluene (BHT) or vitamine E (Palinsky et al., 1989; Morel et 
al., 1984; Steinbrecher et al., 1984) resulting in blockage of several LDL-induced bio-
logical effects (Triau et al., 1988; Quinn et al., 1985; Steinberg et al., 1989). It has been 
shown that high density lipoproteins (HDL) can also prevent LDL-induced effects 
(Hessler et al., 1979). Accordingly, we have investigated the effect of antioxidants and 
HDL on the inhibition of gap junctional communication by LDL, using human arterial 
smooth muscle cells from different origins. 
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MATERIALS AND METHODS 
Reagents 
LDL, HDL and Lucifer Yellow CH were purchased from Sigma Chemicals Co. (St 
Louis, MO, USA). Sodium pyruvate was obtained from BDH Chemicals Ltd (Poole, 
Dorset, UK) and NADH from Boehringer (Mannheim, Germany). BHT and DL-a-
tocopherol were purchased from Merck (Darmstadt, Germany) and dissolved in 95% 
ethanol. Glutathione (GSH) was obtained from Janssen (Beerse, Belgium) and dissolved in 
Eagle's minimal essential medium (EMEM; Flow Labs, UK). 
Cell culture 
Smooth muscle cells were obtained from arteries of human umbilical cords and also from 
thoracic aorta of 56-58-yr-old men, for one microinjection experiment with lipoproteins. 
The adventitial layer was carefully removed by dissection. Intimal-medial expiants (1 
mm2) were placed on coverslips, as described previously (Ross, 1971), and incubated in 
EMEM supplemented with 5% foetal calf serum (FCS; Gibco, U.K.), 5% human serum 
(Sigma), 50 ng gentamycin/ml and 1.5 ßg amphotericin B/ml, in a 37 °C, 5% C02 humi-
dified air environment. Sufficient peripheral growth to permit subcultures was obtained 
after 2-3 wk incubation, and all experiments were performed on cells in passage 2-3. 
These cells grow in a 'hills and valleys' pattern, and were characterized by raising 
fluoresceinated antibodies against smooth muscle actin (Chamley et al., 1977). 
Experimental procedure 
Cells were plated on glass coverslips, in 35 x 10-mm dishes, at a density of 2 x 105 cells 
per dish, and cultured in EMEM supplemented with FCS 5%, human serum (5%) and 
antibiotics. They were pretreated with Ham's F10 medium (Flow) containing 10% 
lipoprotein-deficient human serum (LPDS; Sigma) for 24 h, and exposed to lipoproteins 
and/or antioxidants. 
Lipoproteins were isolated from fresh unfrozen human plasma (Sigma). Lipoprotein purity 
was controlled for breakdown and oxidation products as described previously (Zwijsen et 
al., 1990). Lipoproteins moved as a compact band and the absence of streaks as well as 
low level of malondialdehyde (MDA) in lipoprotein preparations indicated that lipo-
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proteins were not oxidized essentially. 
Measurement of cell-cell communication 
This was performed in confluent cell cultures by the dye-transfer method (Enomoto et al., 
1984). Briefly, fluorescent Lucifer Yellow CH (10% in 0.33 M-lithium chloride solution; 
Sigma) was injected through capillaries using a micro-injectoscope (Olympus), into a cell 
close to the nucleus. The capillaries were prepared by an automatic magnetic puller (tip 
diameter < 1 pm) (Narishige, Tokyo, Japan). During the injection, the cells were main-
tained at room temperature and the transfer to neighbouring cells was observed after 15-
20 min. Since this dye cannot diffuse through the membrane, its transfer into 
neighbouring cells was believed to operate through gap junctional communication 
(Atkinson et al., 1985; Lo and Gilula, 1979; Stewart, 1978). In each cell culture, a 
minimum of 20 individual smooth muscle cells was injected; each experiment was 
performed in triplicate, and at least two independent experiments were done. Statistical 
analyses of the data were performed using Student's t-test. 
Cytotoxicity assay 
The cytotoxicity was determined by the measurement of lactate dehydrogenase released 
into the medium. Confluent cell cultures were exposed to lipoproteins, with or without 
antioxidants, or to antioxidants alone in 6-well dishes (Costar) for 24 h. 400 pi, out of a 
total volume of 2 ml, was taken from each well and centrifuged, and lactate 
dehydrogenase was measured in 100-jul supernatant (Mitchell et al., 1980). The maximal 
release of lactate dehydrogenase was obtained by scraping the cells with a rubber 
policeman in 1 ml Triton X-100 (0.5%) in 0.1 M phosphate buffer, and measuring the 
enzym activity in the supernatant after a 5-min sonification followed by centrifugation. 
Each experiment was performed in triplicate. 
Lipid peroxidation assay 
Lipid peroxidation was determined by the method of Yagi (1976). Confluent cell cultures 
were exposed to 100 Mg LDL-cholesterol/ml, with or without antioxidants, in serum-free 
Ham's medium. After 24 h incubation, 100 p\ of the incubate (without cells) was added 
to 1.5 ml thiobarbituric acid (0.67%) and 1.5 ml Cl3CCOOH (20%). The mixture was 
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heated at 100 °C for 45 min, cooled with water, and immediately assayed fluorometrically 
using an Aminco-Bowman spectrophotofluorometer at excitation and emission 
wavelengths of 515 nm and 553 nm respectively. Freshly diluted malondialdehyde 
bis(dimethylacetal) (1,1,3,3-tetramethoxypropane; Aldrich, Steinheim, Germany) was 
used as a standard. The degree of LDL oxidation is expressed as nmol of MDA 
equivalents/mg LDL-cholesterol. 
Electrophoresis 
This was performed with 20 jul of the same incubates as previously. This volume was 
applied to each lane of the 1 % agarose gel, which was then run in barbital buffer (Sigma) 
for 2 h, dried at 60 °C for 30 min, and lipid-stained with Sudan-black B. The gels were 
destained in a methanol-distilled water (2:1, v/v), rinsed in distilled water and dried. 
Electrophoretic mobility was evaluated by measuring the distance from the origin to the 
middle of the stained bands. The relative electrophoretic mobility was expressed as a ratio 
of the mobility of the sample to that of the control, which consisted of serum-free Ham's 
medium containing 100 ßg LDL-cholesterol. 
RESULTS 
Figure 3.1 illustrates the effect of LDL and HDL on gap junctional communication 
between smooth muscle cells from thoracic aorta and umbilical cords. LDL decreased 
intercellular communication in both type of cells in a dose-dependent manner. However, 
umbilical cord cells respond to lower LDL-concentrations (> 50 ßg LDL-cholesterol/ml; 
p < 0.05) compared with aortic cells (> 100 ßg LDL-cholesterol/ml; p < 0.01). HDL did 
not influence gap junctional communication in either type of smooth muscle cells. 
Table 3.1 shows the effects of the antioxidants BHT (20 ßM), a-tocopherol (100 ßM) and 
glutathione (1 mM) on the inhibition of intercellular communication by LDL. A 38% 
decrease in the communication was obtained by exposing arterial smooth muscle cells to 
LDL (100 ßg LDL-cholesterol/ml) for 24 h. Simultaneous treatment of the cells with 
LDL and antioxidants did not inhibit cell-cell communication, whereas an inhibitory effect 
(-31%) was obtained by adding simultaneously oxidized LDL and BHT (20 Mm) to the 
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Table 3.1 Effect of LDL with(out) antioxidants on intercellular communication. 
incubation conditions intercellular communication 
LDL 
LDL + BHT 
LDL + a-tocopherol 
LDL + glutathione 
BHT 
a-tocopherol 
glutathione 
oxidized LDL + BHT 
100.0 
61.9" 
90.8 
98.9 
91.3 
89.5 
105.7 
105.1 
68.8* 
+ 
± 
+ 
+ 
± 
+ 
± 
+ 
+ 
3.6 
6.5 
10.6 
9.7 
5.0 
8.3 
6.0 
4.9 
7.9 
Smooth muscle cells derived from umbilical cords were incubated with LDL (100 u.g LDL-cholesterol/ml) 
with or without BHT (20 nM), a-tocopherol (100 |iM) or glutathione (1 mM) for 24 h. Oxidized LDL were 
obtained from LDL (100 ng LDL-cholesterol/ml) incubated with cells for 24 h. Intercellular communication 
was measured using a dye-transfer method; the number fluorescent cells in control cultures was approx. 21. 
Each number represents the mean of 120-180 injections from two independent experiments. Values are 
mean ± S.E.M, Asterisks indicate significant differences from controls fpsO.Ol). 
intercellular communication (%) 
100-
0 100 200 
concentration cholesterol(ug/mI) 
Fig. 3.1 Effect of Low Density Lipoproteins (LDL) and High Density Lipoproteins 
(HDL) on gap junctional communication between human smooth muscle cells derived 
from arteries of umbilical cords and thoracic aorta. Circles : LDL treatment; Triangles : 
HDL treatment. Open symbols : cells derived from umbilical cords. Closed symbols: 
cells derived from thoracic aorta. Each point represents the mean of 180-340 injections 
from three independent experiments. Values are mean ± S.E.M.; +p<0.05,*p<0.01 
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Table 3.2 Effect of antioxidants on the inhibition of intercellular communication by LDL. 
Incubation 
conditions 
LDL-control 
SMC alone 
BHT 
a-tocopherol 
glutathione 
No-cell control 
TBARS 
(nmol MDA/ 
mg LDL-chol) 
0.0 ± 0.0 
1.2 ± 0.4 
0.1 ± 0.1 
0.3 + 0.1 
0.2 ± 0.1 
0.7 + 0.3 
electro-
phoretic 
mobility (mm) 
21 ± 1 
26 ± 2 
20 ± 1 
21 + 1 
20 ± 2 
24 + 1 
relative 
electropho-
retic mobility 
1.00 
1.25 
0.95 
1.00 
0.95 
1.14 
LDL (100 \ig LDL-cholesterol/ml) was incubated in Ham's F10 medium with or without antioxidants (20 
lim-BHT, 100 (im-a-tocopherol or 1 mM-glutathione), for 24 h. An aliquot of the medium was then 
assayed for the content of TBARS. A second aliquot was taken for the determination of electrophoretic 
mobility (i.e. the distance from the origin to the middle of the lipid-stained band). The relative electrophore-
tic mobility was expressed as the ratio of the mobility of the sample to that control LDL (no incubation). 
Values are means ± S.E.M. (n=3). 
assay. BHT, a-tocopherol or glutathione, added alone to cell cultures, did not alter 
intercellular communication. The data showed that antioxidants might prevent completely 
the effect of LDL on cell-cell communication. At the LDL concentrations used, the 
lactate-dehydrogenase activity of the assay was 89-104% of the control value, indicating 
that the experiments were performed under non-cytotoxic conditions. The results from the 
lipid-peroxidation assay and gel electrophoresis are shown in Table 3.2. Incubation of 
smooth muscle cells with F10 medium containing LDL resulted in the appearance of 
thiobarbituric acid-reacting substances (TBARS) and an increase in the electrophoretic 
mobility of LDL. These biochemical changes were due to both the components of the 
medium and the smooth muscle cells. LDL electrophoretic mobility correlated well with 
the degree of oxidation of the lipoproteins as measured by the content of TBARS in the 
assay medium. The presence of antioxidants prevented the oxidation of LDL and 
therefore no inhibition of intercellular communication was observed. Figure 3.2 and Table 
3.3 illustrate the influence of HDL on LDL inhibitory effect. Simultaneous treatment of 
the cells with HDL (20-80 Mg cholesterol/ml) and LDL (100, 160 or 250 pg choleste-
rol/ml) significantly reduced (p<0.01), but did not completely prevent the LDL-induced 
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Table 3.3 Restoration of HDL 
communication (%). 
in LDL-induced inhibition of gap junctional 
HDL (jug cholesterol/ml) 
LDL (ßg cholesterol/ml) 
100 160 250 
0 
10 
20 
50 
80 
0.0 
15.4 ± 1.1 
39.1 ± 3.3* 
57.6 ± 7.3* 
74.5 ± 8.9" 
0.0 
23.0 + 2.6 
35.9 ± 6.6' 
47.7 ± 5.0* 
45.7 ± 2.1* 
0.0 
7.2 ± 0.4 
19.2 ± 0.9* 
34.5 ± 1.4" 
30.2 + 0.4" 
Intercellular communication was inhibited to 57.1 ±5.9, 45.3 ±5.2 and 37.4±3.3% by incubating smooth 
muscle cells with LDL at 100, 160 and 250 jig cholesterol/ml, respectively, for 24 h. The values in the 
table indicate the % of reduction in the inhibition of gap-junctional communication obtained by adding HDL 
simultaneously with LDL to the cultures before incubation. Each number represents the mean of 120-140 
injections from two independent experiments. Values are means ± S.E.M. Asterisks indicate significant 
differences from controls (*ps0.01). 
intercellular communication (%) 
10<h 
-r 
40 80 
concentration HDL-cholesterol (ug/ml) 
Fig. 3.2 Effect of combinations of High Density Lipoproteins (HDL) and Low Density 
Lipoproteins (LDL) on inhibition of gap junctional communication between human 
smooth muscle cells. Open symbol: no LDL treatment. Closed symbols : LDL treatment ; 
triangles : treatment with 100 ßg LDL-cholesterol/ml; circles : treatment with 160 ßg 
LDL-cholesterol/ml; squares : treatment with 250 ßg LDL-cholesterol/ml. Each point 
represents the mean of 120-140 injections from two independent experiments. Values are 
mean ± SEM. * p<0.01 compared with LDL treatment alone. 
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inhibition of intercellular communication. The effect of HDL increased in a dose-
dependent manner between 0 and 50 ßg HDL-cholesterol/ml; it reached saturation levels 
at 80 jug HDL-cholesterol/ml when combined with 160-250 ßg LDL-cholesterol/ml. 
Exposure of the cells to the highest HDL dose (80 ßg cholesterol/ml) and increasing LDL 
doses (100, 160 and 250 ßg cholesterol/ml) led to a decrease in the LDL-induced 
inhibition of intercellular communication by 75, 46 and 30% respectively. 
DISCUSSION 
Smooth muscle cells from arteries of human umbilical cords and the thoracic aorta 
responded in the same manner to LDL and HDL as far as intercellular communication is 
concerned. As previously reported (Zwijsen et al., 1990), the present study shows that 
LDL, in contrast to HDL, inhibited intercellular communication in a dosis-dependent 
manner. The simultaneous addition of HDL and LDL to the assay reduced the inhibitory 
effect of LDL on cell-cell communication. This result suggests that the balance between 
LDL and HDL plays an important part in the final effect of intercellular communication. 
This observation is consistent with a number of epidemiological studies indicating that 
high LDL and low HDL concentrations in plasma are associated with the development of 
accelerated atherosclerotic vascular disease (Glueck et al., 1977; Gordon et al., 1977; 
Miller and Miller, 1975; Smith and Slater, 1972). 
The data also show that oxidation of LDL plays an important role in influencing gap 
junctional communication. This reaction is due both to compounds of F10 medium that 
can catalyse peroxidation (i.e. 0.01 /xM-Cu and 3.0 /xM-Fe) and to smooth muscle cells. 
In assays using lipoprotein-deficient serum, the levels of oxidized LDL were much lower 
than those reported in previous studies (Morel et al., 1984; Steinbrecher et al., 1984). 
LDL oxidation was prevented by antioxidants, such as BHT, DL-a-tocopherol and gluta-
thione. This result is in agreement with other studies (Morel et al., 1984; Palinsky et al., 
1989). In addition, it has been reported that HDL can also inhibit the oxidative 
modification of LDL (Parthasarathy et al., 1990). Our study shows that there is a clear 
relationship between LDL oxidation and inhibition of intercellular communication: LDL 
that had been oxidized prior to incubation inhibited intercellular communication; a 
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combination of HDL and LDL reduced LDL-induced effects on cell-cell communication; 
and all the three antioxidants used (BHT, a-tocopherol and glutathione) completely 
prevented the LDL inhibitory effect. These findings suggest that LDL must undergo 
oxidative modification before it can influence cell-cell communication. A previous study 
has also shown that LDL at 100 ßg cholesterol/ml inhibited cell-cell communication after 
at least 7.5 h incubation (Zwijsen et al., 1990). It has been suggested that this retarded 
effect is possibly caused by intrinsic antioxidants as a-tocopherol. LDL, therefore, must 
loose its antioxidants before it undergoes oxidative modification and subsequently acquires 
its inhibitory property (Esterbauer et al., 1987). 
In vivo data have also demonstrated that LDL oxidative modification plays an important 
role in atherosclerosis (Haberland et al., 1988; Palinsky et al., 1989). Using immunocyto-
chemical techniques, the authors have shown that oxidation of LDL occurs in vivo and 
there is an accumulation of oxidized LDL in atherosclerotic lesions. These products of 
lipid peroxidation appear in the form of ceroids and, compared with normal areas, are 
present in greater concentrations in atheromatous plaques (Mitchinson et al., 1985). 
Furthermore, the role of oxidized LDL in atherosclerosis is further supported by 
experiments showing that antioxidant therapy slows the progress of early atherosclerotic 
lesions in receptor-deficient rabbits (Kita et al., 1987). 
The nature of LDL reactive metabolites has not yet been determined. Our results show 
that the simultaneous addition of BHT and oxidized LDL did not modify the inhibition of 
intercellular communication. This finding suggests that the inhibitory effect observed is 
due to oxidized derivatives of LDL and not to free radicals or intermediate substances 
generated during the peroxidative process. The inhibitory compounds may result from the 
oxidation of cholesterol and/or degradation of polyunsaturated fatty acids (Jürgens et al., 
1986). It has been shown that the oxidation of these fatty acids leads to the formation of 
shorter molecules such as malonaldehyde and 4-hydroxynonenal. These aldehyde can bind 
covalently to apolipoprotein B principally through lysine residues, and therefore modify 
the structural and biological properties of LDL (Esterbauer et al., 1987; Steinberg, 1988). 
These alterations lead to an incapacity of the apolipoprotein to recognize LDL receptors in 
smooth muscle cells. This is in agreement with previous findings showing that the LDL 
inhibitory effect is mainly non-receptor mediated (Zwijsen et al., 1990). 
It has been shown that compounds that are associated with atherosclerosis (e.g. high levels 
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of oxidized LDL, low levels of HDL and cigarette-smoke condensate) inhibit the 
communication between vascular smooth muscle cells (Zwijsen et al., 1990). The 
disruption of the growth control by these compounds results in an uninhibited 
multiplication of these cells leading to the formation of atherosclerotic lesions. Modulation 
of intercellular communication therefore may be an essential step in the pathogenesis of 
atherogenesis. We have also demonstrated that umbilical cord cells can be used to 
investigate gap junctional communication between human arterial cells. 
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CHAPTER 4 
EFFECT OF CHOLESTEROL AND OXYSTEROLS ON GAP JUNCTIONAL 
COMMUNICATION BETWEEN HUMAN SMOOTH MUSCLE CELLS 
Intercellular communication is considered to play an essential role in maintaining and 
controlling cell growth, cell differentiation and homeostasis. Cell-cell communication can be 
regulated by factors that influence gap junctional function. In this study it was demonstrated 
that cholesterol and oxidized cholesterol have the potential to modulate gap junctional 
communication between human smooth muscle cells in an opposite way. Cholesterol 
supplementation to human smooth muscle cells resulted in an increase of gap junctional 
communication up to 130% with regard to the control values. However, autooxidized 
cholesterol inhibited gap junctional communication more than 40%. Testing of several pure 
cholesterol oxidation dérivâtes on gap junctional communication demonstrated that all of them 
were capable to inhibit intercellular communication in the order 25-hydroxycholesterol > 
cholestan-3ß,5a,6ß-triol > 7-ketocholesterol > cholesterol 5,6 a-epoxide. The cell-cell 
communication inhibiting potency of these oxysterols are in accordance with their atherogenic 
potency. This implies that cholesterol oxidation products, in stead of pure cholesterol, can 
be promoting factors in the atherogenesis by influencing gap junctional communication 
between arterial smooth muscle cells, the target cells of atherosclerotic lesions. 
This chapter is based on: 
Renate M.L. Zwijsen, Ingeborg M.J. Oudenhoven, Laura H.J. de Haan (1991) Effects of cholesterol and 
oxysterols on gapjunctional communication between human smooth muscle cells. Eur. J. Pharmacol.-
Environmental Toxicology and Pharmacology Section 228 2/3, 115-120. 
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INTRODUCTION 
Intercellular communication mediated via gap junctions is essential to allow coordination and 
control of the proliferation, differentiation and activities of cell populations (Loewenstein, 
1979). Gap junctions have been shown to be involved in a multitude of cellular processes 
ranging from cell synchronization and neuronal function to cell differentiation and 
carcinogenesis (Loewenstein, 1979; Spray and Bennett, 1985; Pitts and Finbow, 1986). 
Moreover, from previous studies the conclusion could be drawn that these processes may also 
play an essential role in the development of atherosclerosis. It was demonstrated that cigarette 
smoke condensate and carriers of cholesterol and lipids in the blood (low density lipoproteins 
(LDL) and high density lipoproteins (HDL)) markedly influence cell-cell communication, 
which correlates with their association for atherosclerosis (Zwijsen et al., 1990; Zwijsen et 
al., 1991). 
Generally in studies on experimental atherosclerosis cholesterol is used to induce 
atherosclerotic lesions. However, there is also evidence that probably not cholesterol, but its 
oxidation products have an atherogenic potential (Van Lier and Smith, 1967/1970; Smith et 
al., 1967; Addis and Park, 1989). In rabbits alimentary hypercholesterolemia led to increased 
levels of lipid oxidation products and to depression of antioxidants systems of blood 
(Ledwozyw et al., 1986; Voskresensky, 1981). A diet poor in antioxidants or containing lipid 
oxidation products accelerated the development of experimental atherosclerosis 
(Voskresensky, 1981). There is also a great deal of evidence showing that oxidative 
modification of LDL, the main carrier of cholesterol, is an essential process in atherogenesis. 
LDL-oxidation is accompanied by the appearance of lipid oxidation products (Steinbrecher 
et al., 1984; Goldstein et al., 1979). Additional evidence for the role of oxidative processes 
in atherosclerosis are the accumulation of lipid peroxides in blood and arterial wall of 
patients with atherosclerotic alterations in blood vessels (Gray et al., 1971; Lopukhin et al., 
1983; Ledwozyw et al., 1986). In the mean time studies have been done with individual 
cholesterol oxidation products, which show that these compounds are far more atherogenic 
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than cholesterol itself (Tayler et al., 1979; Shih, 1980). Consequently, the conclusion can 
be drawn that the deposition of cholesterol and its esters in atherosclerotic lesions is probably 
not direct responsible for initiation of the lesion, but is merely a secondary process (Peng et 
al., 1985 a/b). 
Cholesterol oxidation products are formed both in food as well as endogenously in the body 
tissues. They have been identified in certain processed food, like dried egg products, 
powdered milk, cheese and in a variety of high temperature dried animal products (Chicoye 
et al., 1968; Naber and Biggert, 1982; Bascoul et al., 1986; Addis, 1986). On the other 
hand, the in vivo formation of oxysterols occurs via microsomal and mitochondrial cyto-
chrome P-450 dependent lipidperoxidation and lipid autooxidation (Aringer and Eneroth, 
1974; Martin and Nicholas, 1973; Sevanian et al., 1985). So, in view of the common 
occurence of oxysterols, they may well represent a risk factor in atherosclerotic 
cardiovascular disease. Sofar, the initiating effects of these compounds received more 
attention than their promoting effects in atherogenesis. The main object of the present study 
was therefore to examine cholesterol, autooxidized cholesterol and major known oxysterols 
including cholesterol 5,6 a-epoxide, 25-hydroxycholesterol, cholestan-3ß,5a,6ß-triol and 7-
ketocholesterol with respect to their effects on intercellular communication between human 
smooth muscle cells, a probable promoting mechanism. 
MATERIALS AND METHODS 
Materials 
Cholesterol, oxysterols, essentially fatty acid-free bovine serum albumin and Lucifer Yellow 
were purchased from Sigma Chemicals Co (U.S.A.). The purity of cholesterol and oxysterols 
was confirmed by thin-layer chromatography using ethylacetate-heptane (1:1; by vol.) with 
single spots and these compounds were stored under nitrogen. 
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Cell culture 
Human smooth muscle cells obtained from arteries of umbilical cords (Zwijsen et al., 1990) 
were cultured in Eagle's Minimal Essential Medium (EMEM; Flow Laboratories, U.K.) 
supplemented with 10% fetal calf serum (Gibco, U.K.), gentamycin (50 Mg/ml; Gibco) and 
amphotericin B (1.5 /ug/ml; Gibco) in a 37 °C, 5% C02 humidified air environment. 
Cholesteroloxidation and supplementation 
Cholesterol was oxidized by air at 65 °C during 5 weeks. Oxidation of cholesterol was 
confirmed by thin-layer chromatography. The compounds were dissolved in 96% ethanol and 
added to EMEM containing 10% lipoprotein deficient serum (LPDS; Sigma) and antibiotics. 
During 24 h cell cultures were exposed to this medium. In case of (oxidized) cholesterol 
treatment 5% fatty-acid free bovine serum albumin (BSA) was included in the culture 
medium 24 h prior and during exposure. Control cultures received vehicle and solvent 
without sterols. 
Cytotoxicity assay 
Cytotoxicity tests were carried out in order to avoid interference of cytotoxicity and 
inhibition of intercellular communication. Therefore, smooth muscle cells (2x10s) were 
seeded into 24-well tissue culture plates and (pre)treated with oxysterols (1-10 /uM) or 
cholesterol(mix) (50-400 Mg/nil) as cited above the next day. After exposure cytotoxicity was 
determined morphologically and by measuring of lactate dehydrogenase (LDH) in cells and 
medium as described previously (Mitchell et al., 1980). Each experiment was performed in 
three wells and at least two independent tests were done. It was found that values of LDH 
activities after treatment varied between 94% and 102% of the control values. No 
morphologically changes were seen at concentrations of the compounds used here. So, we 
tested these compounds under non-cytotoxic conditions. 
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Intercellular communication studies 
Intercellular communication experiments were performed as following. Glass capillaries with 
a tip diameter of 1 ßva prepared with a dual-step puller (Narishige Co., Tokyo, Japan) were 
filled with a 20% Lucifer Yellow CH solution dissolved in 0.33 M lithium chloride and fixed 
at an inverted microscope (Olympus Injectoscope IMT-2 SYF). The cells were microinjected 
close to the nucleus. The extent of intercellular communication was determined by the 
number of fluorescent neighboring cells scored under a fluorescence phase-contrast 
microscope 15 min after injection. In each dish containing confluent smooth muscle cell 
culture at least 20 individual cells were injected. Each experiment was performed in three 
dishes, while at least two independent tests were done. 
Statistical treatments 
Values were routinely expressed as means with standard deviations (SD). To determine the 
statistical significance of values obtained with the various treatments, Student's t-test was 
applied. 
RESULTS 
In a first series of experiments pure cholesterol was compared with cholesterol in oxidized 
form. As can be seen in Fig. 4.1 cholesterol even stimulates dye transfer between human 
smooth muscle cells with a maximum of 130% communication at 200 ßg cholesterol/ml 
(p<0.005); At 400 ßg cholesterol/ml the enhanced communication was persisted (p<0.05). 
However, cholesterol which was oxidized by air at 65 °C for 5 weeks reacted oppositive to 
cell-cell communication. The mix of cholesterol dérivâtes caused inhibition of communication 
between the smooth muscle cells in a dosis-dependent manner. Exposure of 100 ßg 
cholesterol dérivâtes mix/ml during 24 h showed an inhibition of 24 % and at the highest 
cholesterol mix concentration used here (400 Mg/ml) the inhibition was increased to 42 % 
61 
intercellular communication (%) 
150-
200 300 400 
concentration cholesterol [(ig/nnl) 
Figure 4.1 Effect of cholesterol and autooxidized cholesterol on gap junctional ommunication 
between human smooth muscle cells. • : cholesterol treatment; o: autooxidized cholesterol 
treatment. Each point represents the mean of 120-240 injections from two independent 
experiments. Values are mean ± S.D.; * p<0.05, " p<0.005. 
(p<0.005). In a second series of experiments the identified oxysterols including cholestan-
3ß,5a,6ß-triol, 25-hydroxycholesterol, cholesterol 5,6 a-epoxide and 7-ketocholesterol were 
tested on their effects on gap junctional communication. As shown in Fig. 4.2 all of them 
were able to reduce intercellular communication. Cholestan-3ß,5a,6ß-triol was tested between 
0.1 tot 10 pM and caused an inhibition of cell-cell communication at concentrations above 
1 MM (p<0.005). Cholestan-3ß,5a,6ß-triol at 1 juM and 10 nM influence the gap junctional 
communication to 72% and 51% communication with regard to the control values, 
respectively (p<0.005). Another oxysterol, 25-hydroxycholesterol, also influences intercel-
lular communication in a dosis-dependent manner. After treatment with 10 ßM 25-hydroxy-
cholesterol there was a communication of 17% left (p<0.005). 
The effects of 7-ketocholesterol on communication between smooth muscle cells at 1 juM, 
5 MM and 10 IJLM was 96%, 80% and 56% with regard to the control values, respectively. 
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In this concentration range cholesterol 5,6 a-epoxide did influence the intercellular communi-
cation to a lesser extent. The maximal influence on communication induced by cholesterol 
5,6 a-epoxide was a reduction of 20% (p<0.05); this extent of reduction occurred at 10 ßM 
cholesterol 5,6 a-epoxide. Resuming the influence of several oxysterols on gap junctional 
communication, it can be concluded that all of the compounds used in this study were able 
to reduce communication in the order 25-hydroxycholesterol > cholestan-3,5,6-triol > 7-
ketocholesterol > cholesterol 5,6 a-epoxide. 
intercellular communication (%) 
15<h 
100-
50-
0.1 1 5 10 
concentration oxysterol l(iM) 
Figure 4.2 Effect of several oxysterols on gap junctional communication between human 
smooth muscle cells. •: cholesterol 5,6 a-epoxide; o: cholestan, 3ß,5a,6ß-triol; ±: 25-
hydroxycholesterol; • : 7-ketocholesterol. Each point represents the mean of 120-180 
injections from two independent experiments. Values are mean + S.D.; * p<0.05; 
**p<0.005. 
DISCUSSION 
The data presented in this report clearly show that exogenous cholesterol can stimulate gap 
junctional communication between human smooth muscle cells. This effect was demonstrated 
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previously in hepatoma cells (Meijer et al., 1990; Malewicz et al., 1990), but it could not 
be shown in V79 fibroblasts (Chang et al., 1988), possibly because of differences in cell 
types and/or cholesterol concentrations used in the last study. It is well known that choles-
terol is an important structural and functional substituent of the cell, especially by moderating 
the fluidity of the membrane (Papahadjopoulos, 1974). Cholesterol prevents the 
crystallization of fatty acyl chains by fitting between them. An opposite effect of cholesterol 
is to sterically block large motions of fatty acyl chains and thereby make the membrane less 
fluidity (Papahadlopoulos, 1974). In addition, gap junctions appear to be characterized by a 
high level of cholesterol (per mg protein) and by a high cholesterol-to-phospholipid molar 
ratio (Meijer et al., 1990). So, an explanation for the observed cholesterol-induced 
stimulation of gap junctional communication could be that cholesterol is required as an 
essential structural component for the function of gap junctions. 
In contrast to cholesterol, a mix of autooxidized cholesterol appeared to inhibit the gap 
junctional communication. Testing of several pure oxysterols increased the evidence that 
cholesterol in oxidized form is capable to inhibit intercellular communication. It was 
demonstrated that all of the oxysterols were capable to reduce intercellular communication 
in the order 25-hydroxycholesterol > cholestan-3ß,5a,6ß-triol > 7-ketocholesterol > 
cholesterol 5,6 a-epoxide. The order found with regard to inhibition of intercellular 
communication equals the reported atherogenic potential (Peng et al., 1985b). Thus, the 
outcome of this study fitt very well in the hypothesis that intercellular communication is 
involved in atherogenesis. Disturbance of intercellular communication by these compounds 
may result in the disturbance of controlling cell growth, differentiation and homeostasis 
(Loewenstein, 1979). Since this control system is absent in atherosclerotic plaque cells this 
can be one mechanism in the promotion of atherogenesis. Therefore, it is relevant to consider 
in further detail the role of oxysterols in membrane and gap junctional functions. 
The incorporation of exogenous oxysterols into plasma membranes of cultured cells has been 
demonstrated repeatedly. In the membrane insertion hypothesis it is envisaged that exogenous 
oxysterol be incorporated into membranes, displacing membrane cholesterol, with 
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accompanying effects on membrane stability and function. Oxysterols possess by a 
combination of inhibition of cholesterol uptake from exogenous sources and inhibition of 
cellular biosynthesis of cholesterol also the capacity to render cells "cholesterol-starved". 
Inhibitory effects of oxysterols on 3-hydroxy-3-methylglutaryl coenzyme A (HMG Co A) 
reductase activity and cholesterol biosynthesis were reported in cultured smooth muscle cells, 
with 25-hydroxycholesterol as the strongest inhibitor (Peng et al., 1979). Other important 
effects of cholesterol oxidation dérivâtes are stimulation of a soluble acid cholesterol ester 
hydrolase, which catalyzes the hydrolysis of cholesteryl esters (Smith et al., 1974) and inhibi-
tion of the uptake of cholesterol (Bing and Sarma, 1975; Peng et al., 1985a). Depletion of 
cellular cholesterol by these processes and oxysterol insertion into membranes diminishes 
fluidity of fatty acid chains of phospholipids within the membranes (Wharton and Green, 
1982; Rooney et al., 1986; Verma et al., 1983). 
Structural studies show that a gap junction consists of two opposed cylindrical units, called 
connexons, each made up of six protein subunits, which delineate an axial aqueous pore 
(Caspar et al., 1977; Unwin and Zampighi, 1980). The effective diameter of gap junction 
channels are performed by a coordinated sliding and tilting motion of the protein subunits, 
which are typically aligned in a helix-like configuration. The fluidity of the acyl chain 
probably provides the required freedom of motion, allowing proteins within the membranes 
to undergo conformational changes, rotational and/or translocational movements associated 
with their activity. Oxysterols diminish fluidity of acyl chains (Verma et al., 1983; Rooney 
et al., 1986) and thereby possibly influence the rotational changes of the subunits of the gap 
junctions resulting in the observed reduction of the intercellular communication. 
The effects of oxysterols acting on cell membranes may involve yet another fundamental 
process for several oxysterols, that of Ca2+ metabolism. The permeability of gap junctions 
is regulated by intracellular levels of the calcium ion. Elevation of the intracellular level of 
Ca2+ leads to a (graded) closure of gap junctions. Oxysterols can modulate Ca2+ influx and 
efflux in cultured cells in different ways, e.g. cholestan-3ß,5a,6ß-triol, 7-ketocholesterol or 
25-hydroxy-cholesterol exposure caused an increased Ca2+ influx (Holmes et al., 1986; 
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Sevanian and Peterson, 1986). However, Ca2+ efflux is increased by cholesterol 5,6 a-
epoxides (Sevanian and Peterson, 1986). So, oxysterols are not always active in the same 
way and can modulate gap junctional communication in different manners. Besides affecting 
Ca2+ channels oxysterols may influence Ca2+ metabolism also via inhibition of the protein 
calmodulin, which is implicated in a variety of Ca2+-dependent events (Tipton et al., 1987 
a,b). This inhibition would have the effect of suppressing actions of Ca2+ on intracellular 
processes, including the Ca2+ calmodulin kinase inhibiting HMGCoA reductase and thereby 
de novo sterol biosynthesis (Beg et al., 1987 a,b) resulting in decreased membrane fluidity 
and gap junction dysfunction. 
It is of great interest and importance that these spontaneously occuring cholesterol oxidation 
products occur in many cholesterol-containing food items. Some of them were found to be 
easily absorbed and selectively transported in very low density lipoproteins (VLDL) and low 
density lipoproteins (LDL) in the blood and ultimately they can be taken up by the target 
cells of atherosclerosis, the smooth muscle cells (Peng et al., 1982). In addition, the present 
study demonstrated that oxysterols markedly influence gap junctional communication at 
physiological conditions. Therefore, oxysterols may be important promoting factors in the 
atherogenesis. 
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CHAPTER 5 
THE PLATELET-DERIVED GROWTH FACTOR CHAIN A GENE IS 
ONE OF THE TRANSFORMING GENES PRESENT IN HUMAN 
ATHEROSCLEROTIC LESIONS 
DNA derived from human aortic plaques has transforming potential. Mice C3H/10T1/2 
cells transfected with human plaque DNA resulted in 0.070 foci//ig DNA. The 
transforming elements in plaque DNA can be transmitted serially and the transformed 
cells are tumorigenic in vivo. The presence of Alu positive signals in primary and 
secondary transformants indicates the presence of human DNA. In this report we 
demonstrate that platelet-derived growth factor chain A (PDGF-A) activation can 
contribute to the pathogenesis of the atherosclerotic plaque. However, the PDGF-A gene 
is responsible for only one of the seven plaque DNA-induced cell transformations 
screened in the present study, which emphasizes the multifactorial nature of 
atherosclerosis. 
This chapter is based on: 
Renate M.L. Zwijsen, Anne Mensink, Leonie H.E. Kockx, Rommert C. van den Bos and Jan H. Koeman. 
Platelet-derived growth factor chain A is one of the transforming genes present in human atherosclerotic 
lesions (in preparation). 
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INTRODUCTION 
Atherosclerotic lesions occur in the innermost layer of the artery wall and consist mainly 
of proliferated smooth muscle cells surrounded by large amounts of connective tissue, 
numerous lipid-loaden macrophages and varying numbers of lymphocytes. Benditt and 
Benditt (1973) showed that human atherosclerotic plaques are monoclonal in origin, 
providing an explanation for the proliferation of smooth muscle cells. In their view cells 
of a plaque are the progeny of a single mutated smooth muscle cell near the site of a 
plaque, which is transformed by mutational or viral events. So, they compared athero-
sclerotic lesions with benign smooth muscle cell tumors of the arterial wall. In favor of 
this hypothesis it was shown that several chemical mutagens (e.g. polycyclic aromatic 
hydrocarbons) can induce atherosclerotic lesions in laboratory animals (Revis et al., 1984; 
Bond et al., 1981; Albert et al., 1975). Furthermore, Majesky et al. (1985) showed that 
focal proliferation of intimai smooth muscle cells can be induced by an initiation-
promotion treatment sequence, analogous to the multistage mechanism demonstrated for 
tumor formation in a wide variety of animal tissues. Treatment with other kinds of cancer 
causing agents like oncogenic viruses (Fabricant et al., 1978) and radiation (Gold, 1961) 
also induced atherosclerosis. 
The hypothesis of atherosclerotic lesions being similar with benign smooth muscle cell 
tumors of the arterial wall implicates an activation of one or more dominantly active 
oncogenes or the loss or inactivation of an active anti-oncogene in plaque cells. The 
involvement of transforming genes in atherogenesis was demonstrated by Penn et al. 
(1986) and Ahmed et al. (1990). These authors demonstrated that transfection of human 
atherosclerotic plaque DNA resulted in a transformation of NIH 3T3 cells. However, 
Yew et al. (1989) failed to observe transforming activity of human plaque DNA in their 
NIH 3T3 cell transformation assay experiments, suggesting that the activation of a 
transforming gene is not a general feature of plaque formation. Regarding the results of 
the experiments pertaining to the monoclonal origin of atherosclerotic lesions we decided 
to search for active transforming gene(s) in human atherosclerotic plaques using 
atherosclerotic lesions of a different origin (human lesions of the aorta in stead of 
coronary artery) and another cell type (C3H/10T1/2) and possibly to identify them. Here 
we show that also human aortic atherosclerotic plaque DNA also contains active trans-
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forming genes. This study also indicates that the platelet-derived growth factor chain A 
(PDGF-A) gene may play an important role in the atherogenesis as one of the several 
transforming genes present in plaque DNA. 
MATERIALS AND METHODS 
DNA samples and transfection 
Human DNA samples were obtained from lesions of the thoracic aorta and from normal 
thoracic aorta by autopsy of men aged 50-69, who had no cancer and no diabetes mellitus 
history. Portions of tissues from five persons were pooled (plaque A, B, C) or several 
plaques derived from one person were pooled (a,b,c,d). DNA from normal aorta, 
umbilical cord artery and C3H/10T1/2 cells were used as negative controls and 
C3H/10T1/2 cells transformed by 3-methylcholantrene (MCA) served as a positive 
control. The tissues were minced and pottered in ice-cold 0.5% NaCl, 5mM EDTA (pH 
7.5) and 3% 4-aminosalicylic acid (BDH, Poole, UK) until complete disruption of tissue; 
cell monolayers were scraped with a rubber policeman, pelleted and resuspended in a 
small volume of 10 mM Tris/lmM EDTA (pH 7.5). 
DNA isolation procedures were carried out by phenol extractions, proteinase K (Merck, 
Darmstadt, Germany) and RNase A (Sigma, St Louis, MO) treatments. Precipitation of 
DNA was performed by 0.4 volumes of 5 M ammoniumacetate followed by 2 volumes of 
isopropanol at room temperature. Precipitated DNA was dissolved in 10 mM Tris/0.2 
mM EDTA (pH 7.5). High molecular weight DNA was used for DNA-mediated transfer 
assays with C3H/10T1/2 clone 8 cells (passage 9-12). C3H/10T1/2 clone 8 cells are mice 
fibroblasts (American Type Culture Collection) that were propagated in Eagle's Minimal 
Essential Medium (Flow Laboratories, U.K.) with 10% fetal calf serum (FCS; Gibco, 
UK). Exponentially growing cells were transfected using the electroporation technique. 
Therefore, 1 x 107 C3H/10T1/2 cells/ml in phosphate buffered saline (PBS) and 20 or 40 
pg DNA in a cuvette with aluminium electrodes were placed on ice for 10 minutes 
allowing the DNA stick to the cells. Electroporation was carried out at 2000 V for 0.9 se-
conds. After another 10 minutes on ice the cells were resuspended in Eagle's Minimal 
Essential Medium (EMEM; Flow laboratories, UK) and 10 % FCS. The cells were 
73 
cultured for four to five weeks in EMEM, 10 % FCS and gentamycin (50 jug/ml) and 
were scored for type III foci (Reznikoff et al., 1973). Foci were picked up by regional 
trypsination or were fixed with methanol and stained with 5% Giemsa. The isolated foci 
cells were grown in mass culture followed by DNA isolation for a second round of 
transfection. 
Southern blot analyses 
DNAs were digested with the restriction enzymes Eco RI or BamH I (Life Technologies 
Inc., Gaithersburg, USA), separated by electrophoresis in horizontal agarose gels and 
transferred to Gene Screen + membrane filters (NEN, Boston, USA). The blots were 
hybridized using the following cloned DNA fragments as probes: human c-sis, pSMl 
(Josephs, 1984) and human PDGF A chain, clone Dl (Bertholtz et al., 1986); probes of 
v-mos, c-myc, v-Ha-ras, N-ras, v-Ki-ras, fos and the human repetitive Alu sequence (a 
300 bp BamHI insert of pBLUR8) were purchased from ONCOR (Gaitherburg, MD). The 
fragments were 32P-labeled by random priming (Feinberg and Vogelstein, 1983). After 
hybridization the filters were washed at 65 °C in 0.5 x SSC or 0.1 x SSC (1 x SSC = 
0.15 M sodium chloride / 0.015 M sodium citrate, pH 7) and 1% SDS (BDH, Poole, 
UK). Autoradiography was performed with X-ray film (Kodak X-Omat) and Lightning 
Plus Intensifying screens (Dupont) for 2-7 days at -80 °C. 
Tumorigenicity 
Tumorigenicity of transformed cell lines was determined in male Sprague Dawley athymic 
nu+/nu+ mice. Cultured transformed cells were trypsinated and resuspended in EMEM. 
The volume was adjusted to a density of 107ml; 0.2 ml of cell suspension was injected 
subcutaneously in the scapular area using a 23 gauge needle. All animals were bred and 
housed under specific pathogen free conditions and were monitored during 10 weeks for 
tumor development. After sacrificing, samples of the tumors were examined 
histologically. 
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RESULTS 
The transforming potential of DNA derived from human atherosclerotic lesions was tested 
by DNA-mediated gene transfer. Transformed cell clones (foci) arose in cells transfected 
with each sample of (atherosclerotic) tissue DNA pooled from five persons (plaque 
A,B,C) and with each sample of pooled plaque DNA from one individual (plaque a,b,c 
and d) as shown in table 5.1. The transfection efficiency (number of foci//xg DNA) for 
plaque DNA ranged from 0.025 to 0.133 foci//Ltg DNA (mean 0.070 foci/jug DNA). No 
foci arose in cells transfected with normal aorta, umbilical cord artery or C3H/10T1/2 
Tabel 5.1 Transforming activity of DNA from human atherosclerotic lesions and 
controls. 
Origin 
Primary transfections 
plaque A 
plaque B 
plaque C 
plaque a 
plaque b 
plaque c 
plaque d 
overall primary transfections 
normal aorta 
umbilical cord artery 
C3H/10T1/2 cells 
MCA-treated cells 
Secondary transfections 
focus 1 
focus 2 
focus 3 
focus 4 
focus 5 
focus 6 
focus 7 
overall secondary transfections 
foci/total plates 
3/9 
8/3 
3/2 
4/5 
2/2 
9/5 
8/5 
0/15 
0/18 
0/4 
5/2 
7/5 
19/9 
8/3 
18/3 
11/5 
29/9 
65/5 
foci/ug DNA 
0.025 
0.138 
0.075 
0.040 
0.050 
0.090 
0.080 
0.071 
<0.003 
<0.003 
<0.013 
0.125 
0.070 
0.106 
0.080 
0.300 
0.110 
0.161 
0.650 
0.211 
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cell DNA indicating the absence of spontaneous cell transformation. DNA derived from 
MCA-induced (primary) transformants was used as a positive control and resulted in a 
transfection efficiency of 0.125 foci//Lig DNA. Plaque DNA-induced foci and MCA-
induced transformants were visible as closely packed and highly overlapping disorganized 
polar spindle cells. Plaque-induced foci cells were isolated and grown in mass culture for 
the isolation of DNA and used in a second round of transfection. The efficiency of 
secondary transfection ranged from 0.070 to 0.650 foci//xg DNA (mean 0.211 foci/^g 
DNA) showing that the transforming elements in plaque DNA can be transmitted serially 
with a transfection efficiency increased about three-fold as compared with the first cycle 
of transfection. The cells transformed by plaque DNA and their secondary transformants 
gave rise to tumors after injection into nude mice (table 5.2) indicating that these cells 
possess tumorigenicity in vivo. All tumors derived from either plaque-DNA-induced 
transformants or MCA-induced transformants, were morphologically similar (Fig 5.1). 
To examine whether the transformed C3H/10T1/2 mouse cells contain human plaque 
DNA sequences hybridization experiments were performed using as a probe the human 
Fig. 5.1 Photographs of C3H/10T1/2 cells in cell culture (a,b) and grown after injection 
in nude mice (c). a. Cell culture of C3H/10T1/2 cells after transfection with C3H/10T1/2 
cell DNA. b. Transformed cells inside a focus type III after transfection with human 
plaque DNA. c. Histological section (Hematoxylin and Eosin stained) of a tumor, arisen 
after injection of (secondary) transformants. 
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Fig. 5.2 Southern blot analysis of 
digests of genomic DNA from 
C3H/10T1/2 cells (10 Mg/lane) after 
DNA-mediated gene t ransfer 
experiments probed with sis, PDGF-A 
and Alu sequences. A. Southern blot 
analysis of EcoRI digests of genomic 
DNA of C3H/10T1/2 cells probed with 
[^-labelled sis fragment. Lane 1, un-
treated C3H/10T1/2 cells; lane 2-4, 
primary transfectants; lane 5, secondary 
transformants; B. Southern blot of 
EcoRI digests probed with PDGF-A 
fragment. Lane 1-3 and 7, primary 
transformants; lane 4-5, secondary 
transformants; lane 6 untreated 
C3H/10T1/2 cells. C. Southern blot of 
Eco RI digests of genomic DNA of 
mice C3H/10T1/2 transformants 
probed with P2P] -labelled human 
repeating Alu sequences. Lane 1,2,4,6 
and 10, primary transformants; lane 3,5 
and 8 secondary transformants, lane 9, 
normal human aorta (0.2 ßg) and lane 7 
control C3H/10T1/2 cells. The sizes of 
the DNA markers on the left are given 
in kb. 
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repetitive Alu sequence, a 300 bp Bam HI insert of pBLUR8. DNA from primary foci 
cells displays a strong hybridization signal over a wide size range of DNA fragments 
(Fig. 5.2). The DNA of normal human aorta and C3H/10T1/2 cells shows positive and 
no hybridization signal with the Alu probe, respectively (Fig. 5.2). Likewise, Alu positive 
signals were present in DNA of secondary transformants (Fig. 5.2) indicating that all 
transformed cells contain human DNA sequences. 
Tabel 5.2 Tumorigenicity of (transformed) C3H/10T1/2 cells 
Origin cells number of mice number of tumors 
C3H/10T1/2 cells 15 0 
primary transformants 25 6 
secondary transformants 22 9 
MCA-induced transformants 6 2 
For the identification of transforming genes cDNAs encoding several known oncogenes, 
as sis, PDGF-A, mos, fos, myc, H-ras, Ki-ras and N-ras were used in hybridization 
experiments with DNA derived from primary and secondary transformants. Hybridization 
patterns of DNAs from (primary as well as secondary) transformants with all the probes, 
excluding PDGF-A, did not differ significantly from those of C3H/10T1/2 cells. DNA 
after Fxo RI digestion hybridizing with a PDGF-A probe shows an extra band of 9.2 kb, 
besides the endogenous molecular weight bands of 16.6 and 6.9 kb of the C3H/10T1/2 
cells in only one of the seven primary and the associated secondary transformed cell lines 
(Fig. 5.2). BamH I digests of genomic DNA of these transformants resulted also in extra 
PDGF-A positive DNA fragments (results not shown). This proves that at least in some 
instances the transforming nature of plaque DNA can be attributed to the presence of the 
human PDGF A gene. 
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DISCUSSION 
This report clearly shows the transforming potential of DNA from human atherosclerotic 
lesions. The human (Alu sequences containing) transforming elements can be transmitted 
serially and in an in vivo assay for tumorigenicity give rise to tumors in athymic mice. 
This provides strong evidence that these lesions are the direct results of activities of 
transforming genes present in fibrous plaques. This finding has important implications for 
the understanding of molecular events taking place in the proliferation of smooth muscle 
cells and the development of atherosclerosis. In particular, they provide a possible 
explanation for the observations of Benditt and Benditt (1973) that atherosclerotic lesions 
undergo monoclonal cell proliferation. In addition, we have shown that in one of the 
seven primary transformants tested a PDGF-A gene is probably responsible for the 
completion of cell transformation. In the other transformants no extra PDGF-A positive 
DNA fragments were seen. So, this indicates that several transforming genes may be 
involved in atherogenesis and the PDGF-A gene being one of them. These data are in 
agreement with the hypothesis that regulation of smooth muscle cell proliferation in 
atherosclerosis is multifactorial. 
The present study shows that DNA derived from aortic lesions has transforming potential 
in C3H/10T1/2 cells, as has DNA from coronary lesions in NIH 3T3 cells (Penn et al., 
1986; Ahmed et al., 1990). Moreover, cultured cells derived from human atherosclerotic 
lesions also possess transforming genes (Parkes et al., 1991). This would indicate that a 
transforming potential detectable in different cell systems is a general feature of plaque 
DNAs from different origins. This is in striking contrast with the study of Yew et al. 
(1989), who failed to find transforming activity of human plaque DNA. Because all these 
studies (including this study) were performed with pooled samples of DNA transforming 
genes possibly only occur in a subset of the human plaques. So, our results emphasize the 
contribution of genetical alterations in atherogenesis, but do not exclude other potential 
mechanisms critical to atherogenesis, such as paracrine growth factor models. 
Our observation that PDGF-A is a transforming gene in human plaque DNA provides 
support for the involvement of an autocrine PDGF-A cycle in smooth muscle cell 
proliferation. PDGF is a basic protein with two disulphide-linked chains, designed as A 
and B, which can form homodimers as well as AB heterodimers. Both chains are 
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produced by macrophages and endothelial cells, and only the A-chain is secreted by 
smooth muscle cells in tissue culture. (Martinet et al., 1986; Sejersen et al., 1986; 
Starksen et al., 1987; Ross, 1986/1990). The genes are located on different chromosomes 
and both possess transforming capacities; the gene encoding the human PDGF-B chain is 
the normal counterpart of the v-sis oncogene (Waterfield et al., 1983; Beckmann et al., 
1988). Detection of enhanced transcription levels of the PDGF-A and PDGF-B genes in 
atherosclerotic lesions as compared with normal arteries indicates that these genes could 
play a role in atherosclerosis (Barrett and Benditt, 1987; Libby et al., 1988; Wilcox et 
al., 1988). Increased concentrations of PDGF-A transcripts have been localized to cells 
inside human atherosclerotic lesions, whereas B chain transcripts colocalized primarily 
with endothelial cells and macrophages (Wilcox et al., 1988; Libby et al., 1988). This 
implicates that plaque cells possess the capacity to produce an endogenous, potentially 
self-stimulatory (autocrine) growth factor. Moreover, PDGF-A gene expression in human 
smooth muscle cells can be induced by atherogens, like (oxidized) low density 
lipoproteins (Zwijsen et al., 1992). These data emphasize the role of PDGF-A in 
atherogenesis and illustrate the interesting parallel between neoplasia and atherosclerosis. 
Otherwise, the present study failed to demonstrate that the sis gene is an active 
transforming gene present in human plaque DNA and therefore PDGF-B might play a 
role in atherogenesis as paracrine proliferation mechanism. 
The question remains which other transforming genes are involved in the development of 
atherosclerosis. The present study indicates that mos, myc, Ha-ras, Ki-ras, N-ras and fos 
are to be excluded. 
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CHAPTER 6 
CELL TRANSFORMING POTENTIAL OF LOW DENSITY 
LIPOPROTEINS 
Arterial smooth muscle œil proliferation is thought to be essential for the development of 
atherosclerotic lesions. The monoclonal hypothesis of atherogenesis proposes that the 
proliferative smooth muscle cells are derived from a stable transformed cell population. 
The present study deliveres for the first time evidence that, except carcinogens as 3-
methylcholantrene (MCA), also 'atherogenic' low density lipoproteins (LDL) possess cell 
transforming potential. LDL caused dose-dependent cytotoxicity and transformation of 
C3H/10T1/2 cells of type II and type III morphology up to 6 transformed cell clones per 
10" survivors in the concentration range of 50-200 ßg cholesterol/ml after 72 h 
treatments. MCA (0.1 Mg/ml) induced morphological transformation of 2.6 foci per 104 
survivors. In a two stage in vitro transformation assay LDL (5-25 ßg cholesterol/ml) 
enhanced MCA-induced cell transformation 2-2.4 fold in a dose-dependent way. 'Non-
atherogenic' high density lipoproteins (HDL) did not induce celtransformation by 
themselves or in an initiation-promotion model. These results show that LDL could act as 
(co)carcinogens. 
This chapter is based on: 
Renate M.L. Zwijsen (1992) Cell transforming potential of low density lipoproteins. Carcinogenesis 13, 
1913-1915. 
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INTRODUCTION 
Proliferation of smooth muscle cells in the intima of arterial vessels has been viewed as a 
key mechanism in atherosclerosis. It has been suggested that the proliferative smooth 
muscle cells are derived from a stable transformed cell population (Benditt and Benditt, 
1973). The link between atherogenesis and carcinogenesis is supported by (a) the 
monoclonal character of lesion cells (Benditt and Benditt, 1973), (b) the presence of trans-
forming genes in atherosclerotic lesions (Penn et al., 1986; Ahmed et al., 1990) and (c) 
the induction of lesions by carcinogens (Albert et al., 1975; Bond et al., 1981; Albert et 
al., 1977; Paigen et al., 1985), radiation (Gold, 1961) and oncogenic viruses (Fabricant et 
al., 1978; Minick et al., 1979). Moreover, atherosclerotic lesions could be induced after a 
sequential treatment of 7,12-dimethylbenz[a]anthracene and methoxamine administrated in 
an initiation-promotion protocol in cockerels (Majeski et al., 1985). 
However, the cell transforming activities of known atherogens have never been 
investigated. Consequently, the present investigation was undertaken to clarify whether 
lipoproteins as low density lipoproteins (LDL) and high density lipoproteins (HDL) 
possess promoting and transforming capacities using C3H/10T1/2 cells. The C3H/10T1/2 
fibroblast cell line has been used as a model system to study oncogenic transformation by 
chemical carcinogens themselves (Reznikoff et al., 1973). The transformation of 
C3H/10T1/2 cells can be observed to proceed through discrete stages of initiation and 
promotion comparable with in vivo transformation (Frazelle et al., 1983; Boreiko, 1985). 
This has permitted use of this cell transformation system for the study of agents that 
transform cells, initiate transformation and enhance (promote) transformation in an 
initiation-promotion sequence protocol. We used 3-methylcholantrene (MCA) as an 
initiator and 12-0-tetradecanoylphorbol-13-acetate (TPA) or lipoproteins as promoters. 
MATERIALS AND METHODS 
Testcompounds used were purchased from Sigma, St. Louis, MO. The lipoproteins LDL 
and HDL were isolated from fresh unfrozen human plasma (Sigma) and were checked for 
their purity as described previously (Zwijsen et al., 1990). 
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For the cell transformation tests C3H/10T1/2 clone 8 cells (passage 11-13) were cultured 
in Eagle's Minimal Essential Medium (EMEM) with 10% fetal calf serum (FCS) and 
gentamycin (50 /xg/ml). 4-5 104 cells were plated in 6 well-plates (Costar) used for cell 
transformation tests and diluted to 300 cells/well for plating efficiency tests to determine 
cytotoxicity. Cells were exposed for 72 h to test compounds in EMEM without serum 
followed by culturing in EMEM supplemented with 10% FCS. In initiation-promotion 
experiments 6 days after plating cells were secondly exposed to the test compounds TPA, 
LDL or HDL in EMEM with 10% lipoprotein deficient serum (LPDS) for two weeks. 
Culture medium was refreshed twice weekly. Control cell cultures without exposure to the 
test compounds were grown in the same medium as treated cells. Five days and five 
weeks after culturing for plating efficiency tests and celtransformation tests, respectively, 
experiments were terminated by fixation with methanol/acetic acid (3:1) followed by 5% 
(v/v) Giemsa staining. The number of cell clones and the total number of foci (type II or 
III as defined by Reznikoff et al. 1973) were scored blind. Twelve wells were used in 
each treatment group and two independent tests were done. 
RESULTS AND DISCUSSION 
Data of the 'two stage in vitro transformation' protocol are summarized in Table 6.1. 
These tests were performed at non-cytotoxic concentrations and untreated C3H/10T1/2 
cells possessed a plating effiency of 17 + 1%. Treatment with the carcinogenic agens 
MCA (0.1 Mg/ml) during the 'initiation' period of three days resulted in 2.6 transformed 
cell clones (foci) per 10" cells. Additional exposure of LDL (5-25 Mg cholesterol/ml) to 
MCA-treated cells in the 'promotion' period resulted in enhancement of transformation of 
type II and type III morphology with a factor 2 - 2.4, which was dose-dependent. HDL 
did not modulate the number of transformed clones induced by MCA. Exposure of 
(sub)confluent cells during the 'promotion' period without MCA pretreatment to LDL or 
HDL did not gave rise to transformed cells. So, the present study using a two stage 
MCA-induced transformation model clearly demonstrated promoting activities of LDL. 
These data corroborate existing data, which demonstrated that atherogens like LDL 
reduced gap junctional communication, a mechanism which could result in promotion of 
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Table 6.1 Two stage in vitro transformation of C3H/10T1/2 cells'. 
Initiator 
(Mg/ml) 
MCAb 
0.1 
-
0.1 
0.1 
0.1 
0.1 
-
-
0.1 
0.1 
0.1 
-
-
-
Promotor 
(Mg/ml) 
TPA 
0.1 
0.1 
LDL' 
5 
10 
25 
5 
10 
25 
HDL' 
5 
10 
25 
5 
10 
25 
No. of tvpe II and tvpe Ill/total No. of wells 
experiment 1 
0+0/12 
26+17/12 
0+0/12 
287+207/12 
52+40/12 
53+36/11 
47+56/12 
0+0/10 
1+0/12 
1 + 1/10 
22+12/12 
19+23/12 
22+9/12 
0+0/12 
0+0/12 
1+0/12 
experiment 2 
0+0/12 
28+18/12 
0+0/12 
313+150/12 
41+48/12 
45+51/52 
65+42/12 
0+0/12 
0+0/12 
2+1/11 
19+28/12 
23+19/12 
27+17/12 
0+0/12 
0+0/12 
0+0/12 
Transforming 
frequency/ 
10" survivors 
0.0 
2.6 
0.0 
35.8 
5.3 
5.6 
6.2 
0.0 
0.1 
0.2 
2.7 
2.5 
2.2 
0.0 
0.0 
0.1 
'Plating efficiency of untreated cells was 17% (range 14% to 20%); absolute no. of clones was 49.8. 
"Relative cloning efficiency of MCA treated cells was 99% (range 92% to 103%). 
'Lipoproteins are expressed as ug cholesterol/ml. 
(abnormal) smooth muscle growth (Zwijsen et al., 1990; Zwijsen et al., 1991). 
Data of the transforming capacity of MCA, LDL and HDL are presented in Table 6.2. 
MCA served as a positive control (3.6 type II and type III foci/well). LDL treatment (50 
Mg cholesterol/ml - 200 /ug cholesterol/ml) for three days led to induction of both type II 
and type III foci (1.1 - 1.3 type II or type III foci/well). As these concentrations are 
cytotoxic in a dose-dependent manner the transforming frequency per 10" survivors ranged 
between 0.8 at 50 Mg LDL-cholesterol/ml to 4.1 at 200 jug LDL cholesterol/ml. Treat-
ment with HDL over the same concentration range as LDL did not result in any 
transformation of C3H/10T1/2 cells. So, of these two lipoproteins, only LDL possessed 
transforming potential over C3H/10T1/2 cells. 
Table 6.2 Transforming potential of MCA, LDL and HDL. 
Treatment Survival" 
(Mg/ml) 
-
MCA 
0.1 
LDL" 
50 
100 
150 
200 
HDL" 
50 
100 
150 
200 
(%) 
100 
98 
91 
71 
24 
18 
98 
102 
94 
97 
No. of type II and 
total No. 
experiment 1 
0+0/12 
24+12/12 
4+5/10 
10+6/12 
9+6/12 
8+7/12 
0+0/12 
0+0/12 
0+0/12 
2+0/12 
type III/ 
of wells 
experiment 2 
0+0/12 
25+25/12 
10+5/12 
7+8/12 
12+5/12 
6+5/12 
0+0/12 
0+0/12 
0+0/12 
0+0/11 
Tra uisforming 
frequency/ 
10" survivors 
0.0 
2.5 
0.8 
1.2 
3.6 
4.1 
0.0 
0.0 
0.0 
0.1 
"Plating efficiency of untreated cells was 17% (range 12% to 21 %); absolute no. of clones was 51.0. 
lipoproteins are expressed as ng cholesterol/ml. 
C3H/10T1/2 cells are immortalized, partially transformed mouse fibroblast cell lines. The 
present study shows that treatment with LDL was sufficient to transform C3H/10T1/2 
cells fully. This indicates that LDL is capable of activating transforming gene(s) leading 
to cell transformation. Recently, it was demonstrated via gene transfer procedures that 
human plaque DNA was capable of transforming NIH 3T3 cells in culture. In a 
concommitant in vivo assay for tumorigenicity these transformants give rise to tumors in 
athymic mice (Penn et al., 1986; Ahmed et al., 1990). If the transforming gene(s) present 
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in atherosclerotic lesions is identified it will become possible to study how specific (envi-
ronmental) agents as LDL interact with this gene. In conclusion, the results of the present 
investigation indicate that the 'atherogenic' LDL possesses cell transforming potential and 
clearly shows that LDL has promoting activities in an initiation-promotion model. In view 
of these findings atherogens may behave like carcinogens with regard to their trans-
forming potency. These findings are consistent with the hypothesis that the intimai proli-
ferating cells present in atherosclerotic lesions are transformed cells (Benditt and Benditt, 
1973). However, further work is needed to demonstrate whether atherosclerotic lesions 
can be considered as neoplasms. 
Acknowledgements 
Thanks to Dr. G.M. Alink for critically reading the manuscript and to the Netherlands 
Heart Foundation, which supported this work by grants (NHS 87.096). 
References 
Ahmed, A.J., O'Malley, B.W., and Yatsu, F.M. (1990) Presence of a putative transforming gene inhuman 
atherosclerotic plaques. Arteriosclerosis 10, 755a. 
Albert, R.E., Nishizumi, M., and Burns, F. (1975) Effect of carcinogens on atherosclerosis in the chicken 
aorta. Proc. Am. Ass. Cancer Res. 16, 25-32. 
Albert, R.E., Van der Laan, M., Burns, F., and Nishizumi, M. (1977) Effect of carcinogens on chicken 
atherosclerosis. Cancer Res. 37, 2232-2235. 
Benditt, E.P., and Benditt, J.M. (1973) Evidence for the monoclonal origin of human atherosclerotic 
plaques. Proc. Natl. Acad. Sei. (USA) 70, 1753-1756. 
Bond, J.A., Gown, A.M., Yang, H.L., Benditt, E.P., and Juchau, M.R. (1981) Further investigation of the 
capacity of PAHs to elicit atherosclerotic lesions. J. Toxicol. Environ. Health 7, 327-335. 
Boreiko, C.J. (1985) Initiation and promotion in cultures of C3H/10T1/2 mouse embryo fibroblasts. In 
Mass, M.J., Kaufman, D.G., Siegfried, J.M.N., Steele, V.E. and Nesnow, S. (eds), Carcinogenesis- A 
comprehensive survey, vol. 8. Cancer of the Respiratory Tract, Raven Press, New York.pp. 329-340. 
Fabricant, C.J., Fabricant, M., Litrenta, M., and Minick, C. (1978) Virus-induced atherosclerosis. J. Exp. 
Med. 22, 335-340. 
Frazelle, J.H., Abernethy, D.J., and Boreiko, C.J. (1983) Factors influencing the promotion of 
transformation in chemically-initiated C3H/10T1/2 CI 8 mouse embryo fibroblasts. Carcinogenesis 4, 709-
715. 
90 
Gold, H. (1961) Production of arteriosclerosis in the rat. Effect of X-ray and high fat diet. Arch. Pathol. 
71, 268-273. 
Majesky, M.W., Reidy, M.A., Benditt, E.P., and Jachau, M.R. (1985) Focal smooth muscle proliferation 
in the aortic intima produced by an initiation-promotion sequence. Proc. Natl. Acad. Sei. (USA) 82, 3450-
3454. 
Minick, C.R., Fabricant, CG. , Fabricant, J., and Litrenta, M.M. (1979) Atheroarteriosclerosis induced by 
infection with a herpesvirus. Am. J. Path. 96, 673-706. 
Paigen, B., Havens, M.B., and Morrow, A. (1985) Effects of 3-methylcholantrene on the development of 
aortic lesions in mice. Cancer Res. 45, 3850-3855. 
Perm, A., Garte, S.J., Warren, L., Nesta, D., and Mindich, B. (1986) Transforming gene in human 
atherosclerotic plaque DNA. Proc. Natl. Acad. Sei. (USA) 83, 7951-7955. 
Reznikoff, CA. , Brankow, D.W., and Heidelberger, C. (1973) Establishment and characterization of a 
cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res. 
33, 3231-3238. 
Zwijsen, R.M.L., de Haan, L.H.J., Oosting, J.S., Pekelharing, H.L.M., and Koeman, J.H. (1990) 
Inhibition of intercellular communication in smooth muscle cells of human and rats by low density 
lipoprotein, cigarette smoke condensate and TPA. Atherosclerosis 85, 71-80. 
Zwijsen, R.M.L., de Haan, L.H.J., Kuivenhoven, J.A., and Nusselder, I.C.J. (1991) Modulation of low 
density lipoprotein-induced inhibition of intercellular communication by antioxidants and high density 
lipoproteins. Fd Chem. Toxic. 29, 615-620. 
91 
CHAPTER 7 
INDUCTION OF PLATELET-DERIVED GROWTH FACTOR CHAIN A 
GENE EXPRESSION IN HUMAN SMOOTH MUSCLE CELLS BY 
OXIDIZED LOW DENSITY LIPOPROTEINS 
Abnormal proliferation of vascular smooth muscle cells is a key event in the formation 
of atherosclerotic plaques in humans. It has been suggested that modulation of platelet 
derived growth factor chain A (PDGF-A) gene expression may contribute to 
atherosclerosis. Using an 'in situ hybridization' technique the present study shows that the 
presence of low density lipoproteins (LDL) induces an eight-fold increased expression of 
the transforming gene PDGF-A in human smooth muscle cells. The influence on PDGF-
A expression only occurred after oxidative modification of LDL, a process known to be 
important in atherogenesis. The non-atherogenic high density lipoproteins (HDL) did not 
modulate the PDGF-A mRNA levels in smooth muscle cells. Consequently, oxidized LDL 
may participate in atherosclerotic lesion formation as a result of autocrine stimulation of 
PDGF-A. 
This chapter is based on: 
Renate M.L. Zwijsen, Sandra C. Japenga, Astrid M.P. Heijen, Rommert C. van den Bos and Jan H. 
Koeman (1992) Induction of platelet-derived growth factor chain A gene expression in human smooth 
muscle cells by oxidized low density lipoproteins. Biochem. Biophys. Res. Commun. 186, 1410-1416. 
93 
INTRODUCTION 
Atherosclerosis is characterized by a nodular proliferation of smooth muscle cells in the 
arterial intima. Platelet-derived growth factor (PDGF) has been hypothesized to be 
responsible for this intimai proliferation in atherogenesis. PDGF is composed of two 
polypeptide chains (A and B) encoded by separate genes (Heldin et al., 1979; Betsholtz 
et al., 1986). The subunits can form dimers in different combinations to create 
biologically active PDGF. Macrophages as well as endothelial cells synthesize both chains 
of PDGF, whereas smooth muscle cells appear to be activated to express only PDGF-A 
(Martinet et al., 1986; Sejersen et al., 1986; Starksen et al., 1987). Recent studies 
demonstrated that PDGF-A transcripts can be localized in intimai lesion cells inside 
human atherosclerotic lesions suggesting an important role of the PDGF-A gene in 
atherogenesis (Wilcox et al., 1988; Libby et al., 1988). 
The observed modulation of PDGF-A expression in atherosclerotic lesions might be 
induced by known atherogens. Factors strongly correlated with atherogenesis are high 
plasma levels of Low Density Lipoproteins (LDL) and low plasma levels of High Density 
Lipoproteins (HDL). There is increasing evidence indicating that atherogenicity of LDL 
is enhanced by oxidative modification (Morel et al., 1984; Steinberg et al., 1989). Large 
amounts of oxidized LDL were shown to be present in atherosclerotic lesions (Haberland 
et al., 1988; Palinsky et al., 1989). However, it is unclear whether such (oxidized) LDL 
stimulates growth factor gene expression. The purpose of this study is to investigate the 
influence of oxidized and native LDL as well as HDL on PDGF-A expression in human 
smooth muscle cells. The present study is the first report on the modulation of PDGF 
chain A expression by LDL using an in situ hybridization technique. LDL appeared to be 
effective only after oxidative modification. 
MATERIALS AND METHODS 
Chemicals 
Salmon sperm DNA (ssDNA), bovine serum albumin (BSA), LDL and HDL were 
purchased from Sigma (St. Louis, MO). The lipoproteins were checked for purity as 
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described previously (Zwijsen etal., 1990). 3H-uridine, 3H-desoxyadenosine triphosphate 
and 3H-thymidine were from Amersham (Buckinghamshire, UK), butylated 
hydroxytoluene (BHT) and formamide were from Merck (Darmstadt, Germany). Total 
yeast RNA and vanadylsulphate were obtained from BDH (Poole, England). 
Probes 
As a probe specific for the PDGF A chain a 1.3 kb Eco RI fragment of a cDNA, Dl 
(Betsholtz et al., 1986) labeled by random priming (Feinberg and Vogelstein, 1983) was 
used. To check for aspecific binding cells were hybridized with pBR322 fragments. Both 
probes were labeled to a specific radio activity of about 10s cpm/^g DNA. 
Smooth muscle cell culture and exposure. 
Smooth muscle cells were isolated from arteries of human umbilical cords. After removal 
of the adventitial layer one mm2 intimal-medial expiants were placed on 18 x 18 mm glass 
cover slips. The expiants were incubated in EMEM (Flow Laboratories, U.K.) 
supplemented with 5% FCS (Gibco, UK), 5% human serum (Sigma, St. Louis, MO) and 
the antibiotics gentamycin (50 Mg/ml) and amphotericin B (1.5 jug/ml) in a 37 °C, 5 % C02 
humidified air environment. After 2 -3 weeks cells derived from the peripheral growth 
zone were subcultured in flasks (Costar) containing EMEM, 10% FCS and the same 
antibiotics. Distinction between smooth muscle cells, fibroblasts and endothelial cells was 
made by means of fluoresceinated antibodies specific against smooth muscle actin 
(Chamley et al., 1977) and the growth pattern of smooth muscle cells in culture ("hills 
and valleys"). All experiments were performed with smooth muscle cell cultures of 
passage 2 through 3 free of fibroblasts and endothelial cells. 
1 x 104 Smooth muscle cells were plated on cover slips at 16 h before treatment. The cells 
were exposed to LDL or HDL for different periods of time and concentrations in F10 
medium (Flow Laboratories, U.K.) containing 10% lipoprotein deficient serum (LPDS, 
Sigma, St Louis, MO) and antibiotics. To study the role of oxidative modification of LDL 
on PDGF-A expression, cells were treated with LDL (50-200 jug cholesterol/ml) in the 
presence of BHT (20 ßM) for 8 h. Control cultures were exposed to F10 medium and 
LPDS without test compounds. 
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In situ hybridization 
Cells were plated on 18x18 mm cover slips coated with 0.5% gelatin. After treatment 
cells were fixed in 4% (w/v) paraformaldehyde and acetylated with 0.1 M triethanolamine 
(pH 8.0) mixed with 0.25% (w/v) acetaldehydanhydride for 10 min. Cells were washed 
with 2xSSC (lxSSC is 0.15 M NaCl, 0.015 M sodium citrate pH 7.0) and then treated 
with a solution of 0.1M glycine, 0.2 M Tris.HCl pH 7.4 for 10 min. Prehybridization 
was performed in 50% (v/v) deionized formamide/2xSSC for 10 min and hybridization 
was done in the same solution after addition of 1 % (w/v) BSA, lOmM vanadylsulphate, 
10% (w/v) dextransulphate, 0.5 mg/ml ssDNA, 2 mg/ml total yeast RNA and 1.2 nglpl 
3H labeled probe (9 ng/coverslip). After hybridization for 20-24 h at 37 °C cover slips 
were washed in 2xSSC/ 50% (v/v) formamide at 37 °C, lxSSC/50% (v/v) formamide at 
37 °C followed by lxSSC at room temperature, each during 10 minutes. The glasses were 
processed for autoradiography using NTB-2 nuclear emulsion (Kodak Co) and exposed 
in the dark at 4 °C for 7 days. After development cells were counterstained with toluidin 
blue. All experiments were carried out in duplicate and for each treatment three cover 
slips were prepared. On each slip 25 cells were scored for the number of silver grains. 
Hybridization levels of a specific mRNA transcript were determined from the number of 
grains per cell after specific hybridization. Background hybridizations were estimated 
from the number of grains per cell after hybridizations with pBR322 as a non-specific 
probe. 
Total RNA assay 
The amount of total cellular RNA in smooth muscle cells was determined to ensure 
comparability. 1 x 105 Cells were plated into 24-wells tissue culture plates (Costar). After 
attachment and (in several cases treatment) cells were exposed to 3H-uridine (10 juCi/ml) 
for 2 h at 37 °C. Cells were washed with PBS and exposed to 5% (w/v) trichloroacetic 
acid (0 °C) to precipitate RNA. Cells were washed with 0.5% (v/v) Triton in 0.1 M 
phosphate buffer (pH 7.5), scraped from the bottom and sonicated for 5 min. After 
centrifugation the radioactivity in the supernatant was measured. Each experiment was 
done in four-fold and at least two independent experiments were performed. 
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Statistical analysis 
The significance of different treatments on PDGF-A gene expression and the amounts of 
total cellular RNA in smooth muscle cells compared with untreated cells were tested with 
a Student t-test. 
RESULTS 
Human smooth muscle cells were treated with LDL or HDL followed by hybridization 
with a probe specific for PDGF-A. The influence of different lipoproteins on PDGF-A 
expression in human smooth muscle cells is shown in Fig. 7.1. The values are corrected 
for aspecific hybridization; in situ hybridization with 3H labeled pBR322 gave rise to 0.33 
± 0.13 grains/cell. Smooth muscle cells contained 0.5-0.6 PDGF-A transcripts/cell under 
culture conditions. Exposure to LDL (100 ßg cholesterol/ml) caused a 4 - 8 fold increase 
in PDGF-A transcripts. The maximal level was found after 8 h of LDL-incubation; under 
these conditions four copies of the mRNA per cell were detected. After 14 h exposure 
to LDL the PDGF-A transcript level diminished to two copies/cell; this value remained 
PDGF-A expression 
(grains/cell) 
20 25 
exposure time (h) 
PDGF-A expression 
(grains/cell) 
150 200 
cholesterol lug/ml) 
Fig. 7.1 Quantification of PDGF-A transcript levels in human smooth muscle cells using 
the 'in situ hybridization' technique after exposure to LDL or HDL for different periods 
at 100 Mg cholesterol/ml (a) and to different concentrations for 8 h. (b). Values are mean 
number of grains per cell ± SEM. Asterisks indicate significant differences from 
untreated cells Cp^0.05; *p<0.01). 
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stable for periods up to 24 h. As shown in Fig. 7.1a HDL did not influence the PDGF-A 
transcript level. After 8 h of LDL treatment the levels were maximal and therefore after 
this period the PDGF-A expression levels were determinated for several LDL and HDL 
concentrations. Fig. 7.1b demonstrates the LDL dose-dependent transcript levels. 
Exposure to LDL (200 p% cholesterol/ml) resulted in 4.7 PDGF-A transcripts/cell 
compared with 0.6 in cultures of untreated smooth muscle cells. HDL treatment (50 - 200 
Mg cholesterol/ml) did not influence PDGF-A expression levels in smooth muscle cells. 
Table 7.1 Quantification of PDGF-A chain transcript levels in human smooth muscle 
cells using the 'in situ hybridization' technique after exposure to low density 
lipoproteins (LDL) in the presence or absence of 20 pM butylated hydroxyto-
luene (BHT). Data are expressed as mean number of grains per cell ± 
S.E.M. 
LDL BHT 
(Mg cholesterol/ml) - + 
0 0.52 ± 0.21 0.71 ± 0.30 
50 1.64* ± 0.52 0.78 ± 0.31 
100 3.16" ± 0.39 0.94 ± 0.25 
200 3.93- ± 0.54 0.60 ± 0.19 
significantly different from the control; psO.05 
significantly different from the control; p^O.01 
To examine the role of oxidative modification of LDL in the LDL-induced gene 
expression cells were incubated with both LDL and the antioxidant BHT (20 pM) for 8 
h. Table 7.1 shows that incubation of smooth muscle cells with LDL (50 - 200 Mg 
cholesterol/ml) in the presence of BHT (20 pM) caused no significant increase in the 
number of PDGF-A mRNAs as compared to untreated cells. Thus, BHT appears to 
prevent the LDL-induced increase of PDGF-A expression. Therefore, oxidative 
modification of LDL is required for modulating PDGF chain A transcript levels. 
Total RNA levels were determined with a 3H-uridine incorporation assay. The means of 
the RNA levels per cell after exposure to LDL or HDL were between 95% and 115% of 
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control values. Therefore, the observed PDGF-A mRNA modulation could not be ascribed 
to changes in total RNA content per cell. 
DISCUSSION 
The present study shows that LDL in contrast to HDL markedly increases PDGF-A 
transcript levels in human smooth muscle cells and that only the oxidized form of LDL 
plays an active role in this context. This observation is consistent with a number of 
studies indicating that the antioxidant BHT causes a blockage of several LDL-modulated 
effects (Morel et al., 1984; Steinberg et al., 1989; Zwijsen et al., 1991). LDL oxidation 
may occur in vivo and in vitro and is completely inhibited by BHT (Haberland et al., 
1988; Palinsky et al., 1989; Morel et al., 1984; Steinberg et al., 1989; Zwijsen et al., 
1991). The fact that antioxidant therapy slows the progress of atherosclerotic lesions has 
provided further evidence that oxidized LDL does play a pathogenetic role in 
atherogenesis (Carew et al., 1987). 
PDGF A gene products possess cell transforming capacities and expression of this gene 
has been found in several sarcoma's (Heldin et al., 1986; Beekman et al., 1988; Rorsman 
et al., 1988). Besides in carcinogenesis, PDGF-A might play an important role in 
atherogenesis. The present report shows that oxidized LDL increased PDGF-A expression 
in vitro. The suggestion that this process may play a role in atherogenesis is strenghtened 
by the observation that both oxidized LDL and increased PDGF-A expression were 
detected in atherosclerotic lesions (Wilcox et al., 1988; Libby et al., 1988; Haberland et 
al., 1988; Palinsky et al., 1989). Moreover, the intimai cells of human atherosclerotic 
plaques were both able to produce PDGF and respond to PDGF (Libby et al., 1988). So, 
oxidized LDL may participate in atherogenesis due to autocrine stimulation of PDGF-A. 
Besides by oxidized LDL, expression of the PDGF A gene could be increased by several 
other substances, including phorbol esters, thrombin and transforming growth factor ß 
(Starksen etal., 1987). 
In this report gene expression in human atheroma was examined by an 'in situ 
hybridization' technique in stead of the generally used method based on the analysis of 
total RNA extracts from cell cultures (Chirgwin et al., 1979; Chomczynski and Sacchi, 
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1987). The approach based on total RNA extracts is useful for evaluating the capacity of 
a defined cell population, such as cell lines, to express a specific gene. However, 
determination of the effects of several treatments on transcript levels in (primary) cell 
cultures demands large numbers of cells. In addition, quantitative comparisons between 
cell isolates subjected to passages in vitro may reflect not only the treatments of the cells, 
but also differences in donors, passage levels and cell densities. The in situ technique is 
a sensitive, powerful method for defining (relative) transcript levels in a few cells of the 
same origin. So, this method offers exceptional opportunities to examine the influence of 
various compounds on the expression of genes in individual cells. 
However, mRNA studies do not prove unequivocally that these cells actually translate this 
message or process it into an active protein product. Furthermore, we cannot rule out the 
existence of variants in biologically active chain A polypeptides, because this can not be 
detected with the in situ hybridization approach used here (Rorsman et al., 1988). 
Benditt proposed that atherosclerosis represents a monoclonal, neoplastic smooth muscle 
cell growth in the intima of arteries (Benditt and Benditt, 1973). This hypothesis was 
supported by the findings that infection with a herpes virus (Marek's disease), radiation 
and carcinogens can produce atherosclerotic lesions (Minick et al., 1979; Gold, 1961; 
Albert et al., 1975). Even focal smooth muscle cell proliferation could be induced after 
a sequential exposure to 7,12-dimethylbenzo(a)anthracene and methoxamine administrated 
in an initiation-promotion protocol (Majesky et al., 1985). Moreover, transforming genes 
were isolated from human coronary artery plaques (Penn et al., 1986; Ahmed et al., 
1990). The findings of the present study also illustrate the parallel between neoplasma and 
atheroma and support the hypothesis that smooth muscle cells possess the capacity to 
produce an endogenous, potentially self stimulatory (autocrine) growth factor, namely 
PDGF-A. 
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CHAPTER 8 
SUMMARY AND CONCLUDING REMARKS 
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The principal lesion characteristic of atherosclerosis is the plaque. This lesion mainly 
consists of smooth muscle cells, connective matrix and large amounts of extracellular 
lipids. Smooth muscle cell hyperplasia is an integral event in atherosclerotic plaque 
formation and the resultant occlusion of blood vessels. These abnormal cell proliferations 
are primarly caused by defects in the autocrine and/or paracrine growth regulation. A 
novel mechanism critical to atherogenesis introduced in the present study is gap junctional 
mediated growth control. The atherogen-induced effects on gap junctional communication 
between human smooth muscle cells are described in chapters 2,3 and 4. The role of 
autocrine growth stimulation in atherogenesis is shown by the demonstration of the 
presence of activated transforming genes in atherosclerotic lesions (chapter 5) and the cell 
transforming potential of (atherogenic) low density lipoproteins (LDL) as shown in 
chapter 6. Chapter 5 also demonstrated that several transforming genes may be present in 
human plaque DNA, one of them being PDGF-A (platelet-derived growth factor chain 
A). The expression of the latter gene can be modulated by oxidized LDL (chapter 7). 
The present investigation provides additional evidence for the hypothesis that autocrine 
production of growth modulating factors may contribute to the characteristic abnormal 
smooth muscle growth in atherogenesis. We demonstrated that lipoproteins with 
atherogenic potential, such as LDL, in contrast to the non-atherogenic HDL, are able to 
transform fibroblasts in vitro. Genetical alteration of intimai cells present in 
atherosclerotic lesions was demonstrated using DNA-mediated transfection techniques. It 
could be demonstrated that human aortic plaque DNA contains active transforming genes, 
as PDGF-A. This is in agreement with studies by Penn et al. (1986) and Ahmed et al. 
(1990), showing transforming genes in human coronary artery plaques. Even DNA of 
cultured human atherosclerotic plaque cells appeared to have cell transforming capacities 
(Parkes et al., 1991). Only Yew et al. (1989) could not demonstrate a transforming 
potential of human plaque DNA. The variable results obtained sofar might indicate that 
different mechanisms are involved. It should be stressed in this respect that in all these 
studies pooled plaque samples were used and it should be realized that the transforming 
potential is not necessarily present in each plaque. The observed transforming potential of 
plaque DNA supports very well the monoclonal hypothesis of Benditt and Benditt (1973). 
They observed that atherosclerotic lesions start as singular focal masses containing 
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monoclonality and suggested that these masses were in general similar to benign tumors 
as observed in other tissues. However, it has been argued that apparent monoclonality 
could also arise because of strong selection pressure favoring a subpopulation of cells, 
although findings of transforming genes, such as PDGF-A, present in atherosclerotic 
lesions and the transforming potential of atherogens indicate the opposite. Additional 
arguments in favor of the monoclonal hypothesis are that tumor initiators like chemical 
mutagens and promutagens (Albert et al., 1975; Bond et al., 1981), radiation (Gold, 
1961) and oncogenic viruses (Minick et al., 1979) can induce atherosclerotic lesions in 
laboratory animals. Hence, molecular alterations underlying the proliferation of smooth 
muscle cells could show resemblance to the molecular events, which are critical in the 
development of cancer. 
The current view on atherosclerosis is based on the "response to injury" hypothesis, 
implying a paracrine stimulation of smooth muscle growth as a result of injury of 
endothelium (Ross, et al., 1976; Ross, 1981). Most of the studies of experimental 
atherogenesis are implemented in the framework with this hypothetical model. Support for 
this hypothesis is based on the following observations. Atherosclerotic lesions can be 
induced in experimental animals by endothelial denudation and factors derived from 
platelets can induce smooth muscle growth in vitro. Injury to arterial endothelium by 
mechanical, chemical, toxic, viral, or immunological agents caused endothelial denudati-
on, and was followed by platelet adhesion and aggregation, with consequent release of 
platelet-derived growth factors (PDGF), in turn leading to migration into and proliferation 
of smooth muscle cell in the intima and secretion of connective tissue components. Over 
the years, the hypothesis has been modified (Ross, 1990). First of all, it became apparent 
that actual denudation was not a consistent early feature of atherosclerosis (Davies et al., 
1976). Secondly, platelet adherence is neither necessary nor sufficient to cause the lesions 
(Schwartz and Reidy, 1987). Presently, the view is: a. the endothelium can respond to a 
variety of stimuli, by subtle changes in function (endothelial dysfunction) and/or by the 
induction of new endothelium properties; thus non-denuding injury may be important in 
initiating the lesions of atherosclerosis and b. platelets are not the sole initiators of smooth 
muscle proliferation, since growth promoting and growth inhibitory factors secreted by 
other cell types, including macrophages and endothelial cells, may modulate smooth 
muscle growth. 
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However, not all observations made can be explained by the "response to injury" 
hypothesis, including the findings that (intimai) smooth muscle cells themselves can 
secrete and can respond to growth modulating factors and the cell transforming potential 
of plaque DNA as demonstrated above, thus implying an involvement of autocrine growth 
stimuli. A good candidate for autocrine growth factor stimulation of smooth muscle cells 
is PDGF-A. High transcript levels of this transforming gene were detected in intimai cells 
of human atherosclerotic lesions (Libby et al., 1988; Wilcox et al., 1988). The present 
study showed that PDGF-A was identified as one of the transforming genes present in 
human plaque DNA and the expression of this gene can be induced by LDL (oxidized). 
HDL, a protective lipoprotein to atherosclerosis, did not modulate PDGF-A transcript 
levels in smooth muscle cells. While both oxidized LDL as well as PDGF-A transcripts 
are detected in atherosclerotic lesions this molecular mechanism could play a role in 
atherogenesis. 
Furthermore, the present study provides strong evidence that disturbance of intercellular 
communication is another mechanism, which is probably important in the etiology of 
atherosclerosis. It is shown that compounds with atherogenic potential inhibit 
communication between human smooth muscle cells. The potency to modulate cell-cell 
communication correlates well with their atherogenic potential. For example, low density 
lipoproteins (LDL) in oxidized form and cholesterol oxidation products inhibited cell-cell 
communication. A non-atherogenic lipoprotein as high density lipoprotein (HDL) did not 
influence gap junctional communication between human smooth muscle cells. Otherwise, 
growth factors like PDGF and EGF can modulate cell-to-cell communication (Maldonado 
et al., 1988; Madhukar et al., 1989). This would imply that both paracrine and autocrine 
growth factor production are involved in atherogenesis, in which their influence on the 
gap junctional mediated growth control mechanism is a vital step in atherogenesis. At this 
stage, disruption of intercellular communication results in an uninhibited multiplication of 
these cells leading to the formation of (monoclonal) atherosclerotic lesions. 
The main conclusion of the present study is that the three phenomena 
1) production of growth modulating factors by vascular cells, including 
endothelium, monocytes, platelets and smooth muscle cells 
2) DNA modification (e.g. PDGF-A) of smooth muscle cells 
3) loss of intercellular communication 
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together are important factors in the process of atherosclerosis. The two main theories on 
atherosclerosis, the "monoclonal" and the "response to injury" theory, are compatible in 
many respects and can be fit into one unifying hypothesis as described in Fig. 8.1 
endothelium 
dysfunction 
platelets/monocytes / A permeability 
adhesion —.. / agents modification 
\ 
growth modulating factors smooth muscle 
secretion ONA modification 
/ 
gap junctional communication 
inhibition 
\ 
smooth muscle proliferation 
Fig. 8.1 Hypothetical scheme of main mechanisms involved in atherogenesis. 
The figure shows that one of the earliest events in atherosclerosis is an increased adhesion 
of monocytes to what appears to be intact arterial endothelium, a phenomenon which can 
be well demonstrated using scanning electron microscopy (Faggiotto et al., 1984). In this 
process lipid factors like hypercholesteraemia and other factors as IL-1 or TNF (which 
introduces adhesion molecules on endothelial cells) are important triggers. As a 
consequence of monocyte emigration, there is focally increased permeability to LDL and 
macromolecules (Territo et al., 1984; Gerrity et al., 1979). An altered endothelial 
function (dysfunction) causing increased permeability may also be induced by risk factors 
such as hypertension, hyperlipidaemia, smoking, immunological factors, stress and 
diabetes mellitus (Reidy, 1985; Sieffert et al., 1981; Gordon et al., 1981, Munro and 
Cotran, 1988). In this way the agents present in the bloodstream (such as LDL) 
accumulate and are modified in the arterial wall and thereafter exert their effects locally 
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on vascular cells. 
The next important step could be DNA modification(s) of smooth muscle cells as shown 
by the presence of transforming genes, as PDGF-A, in lesion DNA and the effects of the 
atherogenic LDL on cell transformation. This defect of an autocrine growth regulation is 
followed by another vital growth control mechanism, the gap junctional communication. 
Communication between human smooth muscle cells has been modified by several 
atherogens, like LDL (oxidized) and oxysterols. In case of impairement of both growth 
regulation mechanisms clonal growth may occur. 
The processes described on the left side of the scheme are consistent with the paracrine 
proliferation mechanism of "the response to injury" theory of Ross (1990). The first 
trigger in this process is a dysfunction of the endothelium. This process introduces the 
adhesion and aggregation of platelets and/or monocytes to the endothelium, which results 
in a release of growth modulating factors as platelet-derived growth factor. At this stage, 
paracrine growth stimulating factors do not yet cause abnormal smooth muscle growth, 
because autonomous growth of cells still is controlled by gap junctional communication 
with surrounding cells. Only when growth factors (and atherogens) inhibit gap junctional 
communication abnormal smooth muscle cell proliferation occurs. Thus, inhibition of gap 
junctional intercellular communication could play a predominant role in the onset of 
atherogenesis. 
A better understanding of these growth modulating processess will improve the possibility 
to study the possible atherogenic properties of chemicals within the framework of 
toxicological research. 
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CHAPTER 9 
SAMENVATTING EN SLOTBESCHOUWINGEN 
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Athérosclérose wordt gekenmerkt door verdikkingen in de arteriole vaatwand, genaamd 
plaques. De lesies bestaan uit gladde spiercellen, bindweefsel en veel extracellulaire 
lipiden. Gladde spiercelhyperplasie is een integrale gebeurtenis in de plaquevorming en 
wordt voornamelijk veroorzaakt door verstoringen van de autocrine en/of paracrine groei 
regulatie. In deze studie worden verstoringen van de intercellulaire communicatie via 
zogenaamde 'gap junctions' als een nieuw mechanisme, relevant voor de atherogenese, 
geïntroduceerd. De effecten van atherogenen op de communicatie tussen humane gladde 
spiercellen worden beschreven in de hoofdstukken 2, 3 en 4. De betrokkenheid van 
autocrine groeistimulatie in de atherogenese wordt duidelijk geïllustreerd door de 
bevinding dat geactiveerde transformerende genen aanwezig zijn in atherosclerotische 
lesies (hoofdstuk 5) en door de celtransformerende eigenschappen van het atherogene 
LDL (low density lipoproteinen), die beschreven staan in hoofdstuk 6. Hoofdstuk 5 toont 
tevens aan dat er verschillende transformerende genen in plaque-DNA aanwezig kunnen 
zijn, waarvan er één geïdentificeerd is als het PDGF-A (platelet-derived growth factor 
chain A) gen. De expressie van dit gen kan gemoduleerd worden door geoxideerd LDL 
(hoofdstuk 7). 
Het onderhavige onderzoek verschaft extra argumenten voor de hypothese, dat autocrine 
productie van groeimodulerende factoren betrokken is bij de abnormale gladde spiercel-
groei, die kenmerkend is voor de atherogenese. Er is onder andere aangetoond dat het 
atherogene LDL, in tegenstelling tot HDL, in staat is om fibroblasten in vitro te 
transformeren. Een directe aanwijzing voor genetische veranderingen van intimale cellen 
in de lesie werd gevonden door gebruik te maken van een DNA transfectietechniek. Er 
kon aangetoond worden dat plaque-DNA uit de humane aorta verschillende geactiveerde 
transformerende genen bevatte, waaronder PDGF-A. Dit is in overeenstemming met 
studies van Penn e.a. (1986) en Ahmed e.a. (1990), die transformerende genen in plaque-
DNA uit humane kransslagaderen aantroffen. Zelfs DNA afkomstig uit gecultiveerde 
humane plaquecellen bleek celtransformerende capaciteit te bezitten (Parkes e.a., 1991). 
Alleen Yew e.a. (1989) kon geen transformerende potentie van plaque-DNA aantonen. De 
reden dat er tot nu toe tegenstrijdige resultaten verkregen zijn kan betekenen, dat er 
verschillende mechanismen aan de etiologie van athérosclérose ten grondslag kunnen 
liggen. In dit verband moet er nadrukkelijk op gewezen worden dat bij al deze studies 
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gebruik is gemaakt van gepoold plaquemateriaal en het dus niet noodzakelijk is dat er 
transformerende genen in élke plaque aanwezig zijn. De waargenomen transformerende 
capaciteit van plaque-DNA steunt de monoclonale hypothese van Benditt en Benditt 
(1973). Zij namen waar dat cellen afkomstig uit atherosclerotische lesies, een 
monoclonaal karakter hadden en verbonden daaraan de conclusie dat dit weefsel in het 
algemeen vergelijkbaar was met goedaardige tumoren. Als tegenargument wordt wel 
aangevoerd dat deze ogenschijnlijke monoclonaliteit veroorzaakt kan worden door sterke 
selectieve druk welke ten goede komt aan een subpopulatie van cellen, alhoewel 
bevindingen zoals de in plaque-DNA aanwezige transformerende genen (waaronder 
PDGF-A) en de transformerende eigenschappen van atherogenen dit tegenspreken. 
Additionele argumenten ten gunste van de monoclonale theorie zijn dat tumor-initiatoren -
-zoals chemische mutagenen en promutagenen (Albert e.a., 1975; Bond e.a., 1981), 
straling (Gold, 1961) en oncogene virussen (Minck e.a., 1979)- lesies in proefdieren 
kunnen induceren, die grote overeenkomsten vertonen met humane atherosclerotische 
plaques. Daarom kunnen de moleculaire veranderingen die ten grondslag liggen aan de 
proliferatie van gladde spiercellen in de atherogenese gelijkenissen vertonen met de 
moleculaire mechanismen, welke betrokken zijn bij de carcinogenese. 
De gangbare opvatting over athérosclérose baseert zich op de 'response-to-injury' 
hypothese. Deze komt er in essentie op neer dat een paracrine stimulatie van gladde 
spiercelgroei het gevolg is van een beschadiging van het endotheel (Ross, e.a., 1976; 
Ross, 1981). Veel studies zijn in het raamwerk van dit hypothetisch model uitgevoerd. 
Steun voor deze hypothese is gebaseerd op de volgende waarnemingen. Bij proefdieren 
kunnen atherosclerotische lesies geïnduceerd worden door de endotheelcellaag te 
verwijderen. Beschadiging van het endotheel (veroorzaakt o.a. door mechanische, 
chemische, toxische, virale of immunologische verbindingen) veroorzaakte adhesie en 
aggregatie van bloedplaatjes gevolgd door afgifte van groeifactoren (zoals PDGF), welke 
aanzette tot migratie van gladde spiercellen naar de intima en proliferatie alsmede secretie 
van bind weefselcomponenten. In de loop der jaren is de hypothese gewijzigd (Ross, 
1990). Ten eerste kwam aan het licht dat een verdwijning van de endotheelcellaag niet 
altijd optrad in de beginfase van de atherogenese (Davies e.a., 1976). Ten tweede is 
adhesie van bloedplaatjes niet noodzakelijk en zeker niet voldoende voor vorming van 
atherosclerotische lesies (Schwartz en Reidy, 1987). Tegenwoordig is de theorie als volgt: 
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a) het endotheel kan op verschillende stimuli reageren door subtiele functionele 
veranderingen (endotheliale dysfunctie) en/of door inductie van nieuwe endotheliale 
eigenschappen; een niet-cytotoxische beschadiging kan dus belangrijk zijn bij het ontstaan 
van atherogenese en b) bloedplaatjes zijn niet de enige initiatoren van gladde spiercel-
proliferatie, aangezien groeibevorderende en groeiremmende factoren door andere 
celtypes (zoals macrofagen en endotheelcellen) uitgescheiden kunnen worden en zodoende 
effect kunnen hebben op de gladde spiercelgroei. 
De 'response-to-injury' theorie kan echter niet alle waarnemingen verklaren, waaronder 
de bevindingen dat (intimale) gladde spiercellen zelf groeimodulerende factoren kunnen 
uitscheiden en hierop kunnen reageren en de celtransformerende eigenschappen van 
plaque-DNA. Dit duidt dus op de betrokkenheid van autocrine groeistimuli in de 
atherogenese. Een goede kandidaat voor autocrine groeifactorstimulatie van gladde 
spiercellen is PDGF-A. Transcriptieniveaus van dit transformerende gen zijn gelocaliseerd 
in intimale cellen van humane atherosclerotische lesies (Libby e.a., 1988; Wilcox e.a., 
1988). Uit het onderhavige onderzoek blijkt dat het PDGF-A gen als één van de 
verschillende transformerende genen in humaan plaque-DNA aanwezig kan zijn en de 
expressie van dit gen kan door LDL (geoxideerd), in tegenstelling tot HDL, geïnduceerd 
worden. Omdat zowel geoxideerd LDL als PDGF-A transcripten in humane 
atherosclerotische lesies gedetecteerd zijn, kan dit moleculaire mechanisme een rol spelen 
in de atherogenese. 
Een mechanisme dat niet eerder in verband is gebracht met de atherogenese is remming 
van de intercellulaire communicatie via zogenaamde 'gap junctions'. Het onderhavige 
onderzoek toont aan, dat een dergelijke remming een belangrijke rol kan spelen bij het 
ontstaan van athérosclérose. Er is gevonden dat verbindingen met atherogene potentie de 
communicatie tussen humane gladde spiercellen remmen. Ook is er een correlatie 
gevonden tussen de mate van modulatie van de cel-cel communicatie en de atherogene 
potentie van de verbindingen. Zo remmen bijvoorbeeld LDL (in geoxideerde vorm) en 
oxysterolen de communicatie via 'gap junctions' tussen human gladde spiercellen, terwijl 
HDL geen invloed hierop heeft. Anderzijds kunnen groeifactoren, zoals PDGF en EGF, 
ook de intercellulaire communicatie beïnvloeden (Maldonado e.a., 1988; Madhukar e.a., 
1989). Dit leidt tot de conclusie dat zowel paracrine als autocrine groeifactorproductie 
betrokken kan zijn bij de atherogenese via de invloed van deze verbindingen op 
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communicatie met omringende cellen. Verstoring van de intercellulaire communicatie zou 
derhalve een kritische stap in de atherogenese zijn, die resulteert in een ongeremde 
celvermeerdering met als uiteindelijk resultaat de atherosclerotische lesie. 
Samenvattend leidt het in dit proefschrift beschreven onderzoek tot de conclusie dat in 
essentie modulering van de volgende drie processen bepalend is voor het ontstaan van 
athérosclérose: 
1) produktie van groeimodulerende factoren door vaatwandcellen, waaronder 
endotheelcellen, monocyten, bloedplaatjes en gladde spiercellen 
2) DNA modificatie (o.a. PDGF-A) van gladde spiercellen 
3) intercellulaire communicatie 
De twee voornaamste theorieën omtrent athérosclérose, de 'monoclonale' en de 
'response-to-injury' theorie, zijn in vele aspecten verenigbaar en kunnen geïntegreerd 
worden in een hypothetisch model zoals schematisch beschreven in Fig. 9.1. 
bloedplaatjes/monocyten 
adhesie 
groeimodulerende factoren 
secretie 
endothelium 
dysfunctie 
A permeabiliteit 
agens modificatie 
\ 
gladde spiercel 
DNA modificatie 
intercellulaire communicatie via 'gap junctions' 
inhibitie 
gladde spiercel proliferatie 
Fig 9.1 Hypothetisch schema van de belangrijkste mechanismen betrokken bij de 
atherogenese 
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De figuur toont aan dat een verhoogde adhesie van monocyten (aangetoond met scanning 
electronenmicroscopie) een van de eerste gebeurtenissen in de atherogenese is (Faggiotto 
e.a., 1984). Belangrijke triggers in dit proces zijn naast lipiden (bijvoorbeeld 
hypercholesteraemie) andere factoren, zoals IL-1 en TNF die adhesiemoleculen op de 
endotheelcellen introduceren. Als gevolg van emigratie van monocyten wordt de 
permeabiliteit van het endotheel voor LDL en macromoleculen vergroot (Territo e.a., 
1984; Gerrity e.a., 1979). Een veranderde functie van het endotheel (dysfunctie) gepaard 
gaande met een verhoogde permeabiliteit kan ook veroorzaakt worden door verschillende 
risicofactoren, waaronder hypertensie, hyperlipidaemie, roken, immunologische factoren, 
stress en diabetes mellitus (Reidy, 1985; Sieffert e.a., 1981; Gordon e.a., 1981; Munro 
en Cotran, 1988). Op deze manier accumuleren agentia (o.a. LDL) uit het bloed in de 
vaatwand, waar deze vervolgens gemodificeerd kunnen worden en hun effect lokaal op 
vaatwandcellen kunnen uitoefenen. 
De volgende belangrijke stap zou DNA modificatie van gladde spiercellen kunnen zijn. 
Belangrijke argumenten hiervoor zijn, dat transformerende genen (o.a. PDGF-A) in 
plaque-DNA aanwezig zijn en dat het atherogene LDL celtransformerende eigenschappen 
bezit. Deze verstoring van een autocrine groeiregulatie kan gevolgd worden door een 
inhibitie van communicatie via 'gap junctions'. Gevonden is dat communicatie tussen 
humane gladde spiercellen gemodificeerd kan worden door verschillende atherogenen, 
waaronder LDL (geoxideerd) en oxysterolen. Het model impliceert dat in geval van 
verzwakking van beide groeiregulatiemechanismen clonale groei kan optreden. 
De processen beschreven aan de linkerzijde van het schema zijn consistent met het 
paracrine proliferatiemechanisme, dat kenmerkend is voor de 'response to injury' theorie 
van Ross (1990). De eerste trigger in dit proces is een dysfunctie van het endotheel. Dit 
leidt vervolgens tot adhesie en aggregatie van bloedplaatjes en/of monocyten aan het 
endotheel met als gevolg een afgifte van groeimodulerende factoren, zoals PDGF. In deze 
fase veroorzaken paracrine groeifactoren nog geen ongecontroleerde gladde spiercelgroei, 
omdat autonome celgroei nog steeds wordt voorkomen door de groeiregulerende invloed 
van de omringende cellen. Echter indien groeifactoren (en atherogenen) de communicatie 
met omringende cellen via 'gap junctions' remmen kan abnormale gladde spiercelgroei 
optreden. 
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Toegenomen inzicht in de groeimodulerende processen zal betere mogelijkheden bieden 
eigenschappen van stoffen te onderzoeken die relevant zijn voor de atherogenese in het 
kader van toxicologisch onderzoek. 
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